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VOLUMETRIC, MAGNETIC RESONANCE-VISIBLE, AND RADIATION-SENSITIVE
DETECTORS FOR MAGNETIC RESONANCE IMAGE-GUIDED RADIATION THERAPY

Hannah Jungeun Lee
Advisory Professor: Geoffrey S. Ibbott, Ph.D.

Due to the superior soft-tissue contrast of magnetic resonance imaging (MRI) compared to
conventional computed tomography (CT) and other on-board imaging techniques, several groups have
integrated MRI and radiation treatment machine systems. The advent of MR image-guided radiation
therapy (MR-IGRT) using systems, such as the 1.5 MRI – 7 MV linear accelerator (MR-Linac), now
allow for improved soft-tissue on-board imaging for patient position and tumor target localization
verification and the ability to assess functional biological tissue characteristics with MRI, all without
increasing the patient radiation burden.
However, with the advantages of MRI guidance in MR-IGRT came the dosimetric challenges
of the presence of a strong magnetic field. When the magnetic field is oriented perpendicular to the
radiation beam, Lorentz forces act on secondary electrons causing hot and cold spots at tissue transition
areas. These interactions with the magnetic field cause perturbations of the dose distribution in three
dimensions. Current vendor-supplied electronic quality assurance tools can provide at best quasi-3D
sampling of the dose distribution and cannot be MR imaged. As a result, there was a growing need for
volumetric, MR-visible, and radiation-sensitive detectors for MR-IGRT applications. To fill this need
for volumetric dose quality assurance, this dissertation work investigated existing and novel
formulations of radiochromic gel dosimeters. After the optimal radiochromic gel formulation was
identified, it was characterized for dose linearity, radiological properties, reproducibility, time stability,
energy dependence, reusability, dose rate dependence, fractionation dependence, gel matrix
dependence, and diffusion. Next, strong magnetic field and gradient field/radiofrequency effects on the

vii
response of 3D dosimeters were assessed along with other MR considerations that were and were not
specific to MR-IGRT systems. Finally, heterogeneous and homogeneous 3D dosimeters were used for
end-to-end testing with a variety of Monaco TPS plans.
This dissertation work contributed significantly to the fields of 3D dosimetry, MR-IGRT, and
radiation physics: the first proof of concept of real-time 2D and 3D dose acquisition during irradiation
was presented, a novel radiochromic gel dosimeter and its reusable version were presented and
characterized, and the first full end-to-end testing including adaptive planning using daily MR images
of the 3D dosimeters was presented. Overall, the feasibility and benefit of MR-visible and radiationsensitive 3D dosimeters were presented in this dissertation work for MR-IGRT applications.
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Chapter 1 – Introduction

1.1 Integrated magnetic resonance imaging – radiation therapy systems
Prior to delivering patient radiation treatments, conventional treatments utilize some form of
on-board imaging technique, both to ensure the consistency of the daily overall positioning of the
patient as well as ensuring that the tumor target is within the radiation beam path. These imaging
techniques include on-board megavoltage (MV) and kilovoltage (kV) imagers, cone beam computed
tomography (CBCT), CT on rails, time-of-flight (ToF) cameras, and more sophisticated combinations
of x-rays and cameras such as the Brainlab ExacTrac® [1–12]. However, MV and kV images provide
poor soft-tissue contrast compared to magnetic resonance imaging (MRI) and rely largely on bony
anatomy for patient positioning, assuming that the tumor has not moved relative to the bony anatomy.
These conventional techniques also add to the overall radiation burden of the patient, which is
especially of concern for pediatric patients. ToF cameras and other similar techniques only utilize the
surface of the patient, again assuming that the tumor has not moved relative to the patient skin.
However, tumors do not always behave idealistically and are known to change shape, move due to
surrounding organs during treatment, and move due to overall patient weight changes between
treatment fractions [13–18]. While patient immobilization techniques are used to help mitigate set-up
uncertainties, several of these changes cannot be controlled. These changes can occur between the time
of CT simulation and radiation treatment, daily due to inherent patient motion such as breathing, and
gradually throughout treatment due to patient weight changes or disease progression or shrinkage.
Larger planning target volumes (PTVs) have been implemented to account for tumor localization errors
at the cost of unnecessarily irradiating adjacent normal tissues and organs at risk. Attempts have been
made to mitigate these concerns with the use of fiducials, acquiring CTs more frequently during the
course of treatment, and breath-hold and gating techniques to account for respiratory motion. However,
the use of MRI is superior to such methods for soft tissue targets that may not necessarily track
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according to bony anatomy or skin surface motion without adding any radiation burden to the patient,
and the integration of MRI has been proposed by several groups for these reasons.
Due to the superior soft-tissue contrast of MRI compared to conventional computed
tomography (CT) and cone-beam CT, several groups have designed integrated MRI with radiation
treatment machine systems. These include the pre-clinical 1.5 T MRI – 7 MV linear accelerator (linac)
(MR-Linac, Elekta, AB, Stockholm, Sweden), a prototype system combining a 1.0 T MRI with a 6 MV
linac (Ingram Institute, Sydney, Australia), the Aurora RTTM 0.5 T magnet with 6 MV linac (MagnetTx,
Saskatchewan, Canada), and the MRIdianTM 0.35 T magnet with cobalt-60 (Viewray, Inc., Oakwood
Village, Ohio, USA) (Figure 1) [19–23]. Both the Elekta MR-Linac and the Viewray MRIdian consist
of a radiation beam perpendicular to the MRI magnetic field. The Elekta MR-Linac and the Viewray
MRIdian both orient their radiation sources (linac assembly or cobalt-60 sources) on a rotating gantry
surrounding the MRI. The Viewray MRIdian consists of a split magnet design to allow for a lower
source beam energy whereas the Elekta MR-Linac requires the flattening filter free (FFF) radiation
beam to pass through the cryostat. In the Elekta MR-Linac, active magnetic shielding is used around
the linac, and the magnet design reduces the fringe field to minimize any magnetic field effects on the
accelerator components. The Sydney MRI-linac is designed to function with the linac component
switching between parallel and perpendicular configurations with respect to the magnetic field. The
MagnetTx Aurora RTTM consists of a cryogen free bi-planar rotating magnet with the linac oriented
parallel to the MRI magnetic field. Unlike the other aforementioned systems, the MagnetTx Aurora
RTTM is designed with concurrent rotation of the linac and MRI components. The Sydney MRI-linac
and the MagnetTx Aurora RTTM have the advantages of positioning the radiation beam parallel to the
MRI magnetic field, therefore reducing influences of the magnetic field on the radiation dose
distribution. The disadvantages of the Viewray MRIdian and MagnetTx Aurora RTTM are their lower
magnetic field strengths, 0.35 T and 0.5 T, respectively, reducing the MRI signal-to-noise ratio (SNR),
overall image quality, and potential for advanced functional MRI techniques. However, the lower
magnetic field strengths do have the advantage of minimal influences on electronic devices, medical
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devices such as MR-compatible pacemakers, and simplifying dosimetry as a result of less influence on
secondary charged particles. While the Sydney MRI-linac combines the stronger magnetic field
strength advantage of the Elekta MR-Linac along with its dual orientation possibility, this system has
not yet been developed into a functional product to date. For several of the mentioned reasons, the
University of Texas MD Anderson Cancer Center obtained the 2nd worldwide and 1st North American
Elekta MR-Linac system and is the main MR-IGRT system discussed in this dissertation work.

Figure 1: Illustrations of a) the pre-clinical 1.5 T MRI – 7 MV linear accelerator (linac) (MR-Linac,
Elekta, AB, Stockholm, Sweden) (Raaymakers BW, Lagendijk JJW, Overweg J, Kok JGM,
Raaijmakers AJE, Kerkhof EM, van der Put RW, Meijsing I, Crijns SPM, Benedosso F, van Vulpen
M, de Graaff CHW, Allen J, Brown KJ (2009) Integrating a 1.5 T MRI scanner with a 6 MV
accelerator: proof of concept. Phys Med Biol 54:N229–N237. doi: 10.1088/0031-9155/54/12/N01)
(© Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing.
All rights reserved.), b) the 1.0 T MRI with 6 MV linac in Sydney for inline (left) and perpendicular
(right) configurations (Keall PJ, Barton M, Crozier S (2014) The Australian Magnetic Resonance
Imaging–Linac Program. Semin Radiat Oncol 24:203–206. doi: 10.1016/j.semradonc.2014.02.015)
(© Seminars in Radiation Oncology. Reproduced by permission of Elsevier. All rights reserved.), c)
the 0.5 T with 6 MV Aurora RTTM (MagnetTx) (Fallone BG (2014) The Rotating Biplanar Linac–
Magnetic Resonance Imaging System. Semin Radiat Oncol 24:200–202. doi:
10.1016/j.semradonc.2014.02.011) (© Seminars in Radiation Oncology. Reproduced by permission
of Elsevier. All rights reserved.), and d) the 0.35 T with cobalt-60 or linac MRIdian (Viewray, Inc.)
(Mutic S, Dempsey JF (2014) The ViewRay System: Magnetic Resonance–Guided and Controlled
Radiotherapy. Semin Radiat Oncol 24:196–199. doi: 10.1016/j.semradonc.2014.02.008) (© Seminars
in Radiation Oncology. Reproduced by permission of Elsevier. All rights reserved.).
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Compared to conventional on-board imaging acquired for patient position verification on a
linac, MRI has numerous advantages: a variety of acquisition parameters and resulting image contrast
to more accurately localize soft tissues; the ability to reflect functional biological tissue characteristics
such as tissue oxygenation and perfusion; and the ability to image without increasing the patient
radiation burden [24–35]. The integration of MRI with radiation treatment machine systems will
especially benefit patients with soft tissue lesions that are more difficult to track using conventional onboard techniques [36–38]. Encouraging preliminary patient data have been presented for pancreas and
gastrointestinal sites using the MRIdian [39, 40]. Furthermore, the integration of MRI with radiation
treatment machine systems is not limited to the daily advantage of patient and tumor tracking. As
mentioned previously, MRI can provide valuable functional imaging to assess tumor morphology and
response to radiation treatment. Predicting the radiation treatment response for each patient using
functional MRI techniques could enable more personalized and daily adaptive treatments, therefore
making it possible to deliver higher rates of curative treatment while minimizing normal tissue
toxicities. MRI may be able to provide more accurate target delineation for certain tumor sites during
treatment planning, and creating pseudo-CT data sets from only MRI are under development [41–50].
With the advantages of real-time MRI guidance came the dosimetric challenges of the presence
of a strong magnetic field. The focus of this dissertation work was for the 1.5 T – 7 MV Elekta MRLinac. As mentioned previously, the MR-Linac system consists of a radiation beam perpendicular to
the strong magnetic field, with the linac components mounted on a rotating gantry around the MRI
(Figure 1). When the magnetic field is oriented perpendicular to the radiation beam, Lorentz forces act
on secondary electrons causing hot and cold spots at tissue transition areas, such as a radiation beam
exiting from tissue into air (Figure 2 shows Monte Carlo calculated point spread kernels of secondary
electrons at different magnetic field strengths) [51–58]. These changes in the electrons’ trajectories in
the magnetic field cause perturbations of the dose distribution in three dimensions throughout
heterogeneities present in human anatomy, such as areas including the trachea and sinuses.
Conventional quality assurance tools include point measurements using ionization chambers,
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thermoluminscent dosimeters, and optically stimulated luminescence detectors, planar measurements
using film or 2D arrays such as the Sun Nuclear IC Profiler and PTW Starcheck, and quasi-3D arrays
using the Sun Nuclear ArcCHECK. Vendors are beginning to supply magnetic field-compatible quality
assurance tools, but these can provide at best quasi-3D sampling of the dose distribution [59]. Along
with the newfound possibility for real-time MRI during irradiation, integrated MRI with radiation
treatment machine systems have increased the clinical interest for water-equivalent volumetric
dosimeters.

Figure 2: Monte Carlo calculated point spread kernels of secondary electrons for a) 0 T, b) 0.2 T, c)
0.75 T, and d) 1.5 T magnetic field strengths (Raaijmakers AJE, Raaymakers BW, Lagendijk JJW
(2008) Magnetic-field-induced dose effects in MR-guided radiotherapy systems: dependence on the
magnetic field strength. Phys Med Biol 53:909–23. doi: 10.1088/0031-9155/53/4/006) (© Institute of
Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights
reserved.).

1.2 Three-dimensional dosimetry
The introduction of using chemicals that react to byproducts of ionizing radiation in a medium
to measure radiation dose dates back to at least 1927 when Fricke and Morse presented ferrous sulfate
solutions [60]. Since then, such chemical formulations have been incorporated into matrixes allowing
for volumetric or three-dimensional (3D) measurements of radiation dose (dosimeters). Currently
existing 3D dosimeters can generally be classified into 3 categories: radiochromic gels, polymer gels,
and radiochromic plastics.
Radiochromic gels respond to the absorption of radiation dose by producing an optically
readable response. The most common radiochromic gel formulations are based on Fricke and Morse’s
works [60, 61]. The chemical foundation of formulations based on this work relies on the conversion
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of iron(II) (ferrous, Fe2+) to iron(III) (ferric, Fe3+) due to radiolysis of water producing H·, HO·, H2,
and H2O2 and can be described by the following equations in the presence of oxygen:
H · + O2 → HO2 ·

(1)

3+
HO2 · + Fe2+ → HO−
2 + Fe

(2)

+
HO−
⇌ H2 O2
2 + H

(3)

Fe2+ + H2 O2 → Fe3+ + HO− + HO ·

(4)

Fe2+ + HO · → Fe3+ + HO−

(5)

giving the overall yield (G = molecules formed per 100 electron volt (eV) absorbed) of iron(III):
𝐺(Fe3+ ) = 3𝐺(H ·) + 𝐺(HO ·) + 2𝐺(H2 O2 )

(6)

[62]. The production of iron(III) after absorption of radiation can also be related to dose with the
following relationship:
Δ[Fe3+ ] =

𝐷 ∙ 𝐺(𝐹𝑒 3+ ) ∙ 10𝜌
𝑁𝐴 ∙ 𝑒

(7)

where D is radiation dose, ρ is the density in kg/liter, NA is Avogadro’s number (the number of units in
one mole of any substance, 6.022 x 1023), and e is the number of Joules per eV [63]. As can be seen in
equation (7), the dose absorbed by an irradiated Fricke gel can be directly related to the change in
concentration of iron(III). Radiochromic gels’ response to radiation can be read out using optical or
magnetic resonance methods. Optically, the yield or concentration of iron(III) can be related to dose
with the following relationship:
𝐷=

𝑁𝐴 ∙ 𝑒
𝑂𝐷(𝐷) − 𝑂𝐷(0)
∙
3+
𝜌 ∙ 𝑙 ∙ 𝐺(𝐹𝑒 )
𝜀𝑚

(8)

where l is the optical path length (1 cm for standard cuvettes), OD is the optical density, and ε m is the
molar extinction coefficient for iron(III) [63]. The OD of a material is related to the intensity of light
after attenuation through the material, as explained by the Beer-Lambert Law:
𝐼(𝜆) = 𝐼0 (𝜆) ∙ 𝑒 −𝜇(𝜆)𝑥

(9)
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where I0(λ) is the initial light intensity for a given wavelength and μ is the linear attenuation coefficient
(cm-1). OD can then be calculated using the following relationship:
𝐼
𝑂𝐷 = −𝑙𝑜𝑔10 ( )⁄𝑠𝑎𝑚𝑝𝑙𝑒 𝑙𝑒𝑛𝑔𝑡ℎ = 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒⁄𝑠𝑎𝑚𝑝𝑙𝑒 𝑙𝑒𝑛𝑔𝑡ℎ
𝐼0

(10)

where OD has the unit of cm-1. OD by definition is a measure of absorbance and includes both
absorption and scattering of light. Transmittance, on the other hand, is equal to the final light intensity
divided by the initial light intensity. A material will absorb light when the energy of the light matches
the available energy states in the atoms and molecules; otherwise, the light will scatter in a different
direction from the incident light.
Due to paramagnetic differences between ferrous (iron(II)) and ferric (iron(III)) ions of iron,
un-irradiated and irradiated Fricke gels can also be quantified using MR signals. The differences in the
number of unpaired electrons and structure of complex formation for the iron ions affect the magnetic
moment (can be simplified to spin only magnetic moment) and magnetic susceptibility of the material
and are proportional to sqrt(n(n+2)) and n(n+2), respectively, where n is the number of unpaired
electrons [64]. Spin-lattice relaxation rate R1 (=1/T1 where T1 is the longitudinal relaxation time)
radiation-induced changes can be detected on MRI [60, 65–69]. The signal intensity of an MR image
is proportional to the following relationship:
𝑆 ∝ 1−𝑒

𝑡
−( )
𝑇1

(11)

where S is the signal intensity, t is time, and T1 is such that the signal decreases to 63% (or 1-e-1) of its
initial value. The relaxation rate R1 is dose dependent and can be related to the concentration of iron(III)
with the following equation:
3+
𝑅1 (𝐷) = {(𝑟𝑒𝑓𝑓
− 𝑟 2+ ) ∙ 𝐺(𝐹𝑒 3+ ) ∙

10𝜌
} ∙ 𝐷 + 𝑅1 (0)
𝑒 ∙ 𝑁𝐴

(12)

where R1(0) is the relaxation rate of the un-irradiated dosimeter, r3+ is the relaxation enhancement
parameter (or relaxivity) for iron(III) and r2+ is the relaxivity for iron(II) [63]. The relaxivity for iron(III)
is an effective relaxivity since it is dependent on the gel matrix that in turn, affects the complex
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formation and hydration of iron(III). The relaxivities in relation to the dipole-dipole interactions (both
scalar and dipolar coupling between nuclear and electron spins) in the material between water proton
nuclear spins and paramagnetic ions were mathematically described under Solomon-BloembergenMorgan (SBM) theory of relaxation [70–72]. The gyromagnetic ratio of electrons is larger than that of
the hydrogen proton, resulting in a quadratically larger interaction between an electron in the iron ion
and the proton versus the interaction between two protons. The unpaired electrons of any paramagnetic
material cause fluctuations in the local magnetic field, resulting in changes to the relaxivities. The SBM
theory has since been expanded upon, such as using the Lipari-Szabo correction, the modified Florence
approach, and the Swedish slow-motion theory to further explain paramagnetic related relaxivities [73–
77]. While this explicit relationship in equation (12) is only true for iron(II) and iron(III) in solution
and the relaxation models become more complex in a gel matrix, equation (12) still holds true for Fricke
gels incorporated into any gel matrix as the new spin environments are incorporated through the
relaxation rate of the un-irradiated dosimeter R1(0) [63]. The linear relationships between R1 and
radiation dose and MR signal intensity (arbitrary unit) and radiation dose have previously been
reported, and equation (12) can be rearranged to more clearly demonstrate the relationship between net
R1 and dose:
𝐷=

𝑁𝐴 ∙ 𝑒
𝑅1 (𝐷) − 𝑅1 (0)
∙
3+
3+
10𝜌 ∙ 𝐺(𝐹𝑒 )
𝑟𝑒𝑓𝑓
− 𝑟 2+

(13)

[78–81]. Using an MRI system, the R1(D) or T1(D) values can be calculated using a series of sequences,
the gold standard being inversion recovery. The MR signal as a function of T1 can be expressed as the
following from Bloch equation derivations:
𝑆 = 𝑘 ∙ [𝐻] ∙ (1 − 2𝑒 −𝑇𝐼⁄𝑇1 + 𝑒 −𝑇𝑅⁄𝑇1 )

(14)

where k is a scaling factor, [H] is the proton spin density, TI is the inversion time, and TR is the
repetition time (time interval that inversion recovery sequence is repeated). However, these sequences
can take upwards of 20 minutes for a single slice using the inversion recovery methodology, during
which time the iron ions would be diffusing. While faster techniques exist, including Look-Locker and
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Modified Look-Locker Imaging (MOLLI), these were not yet available on the MR-Linac system at the
time of this dissertation work. Since the goal of this dissertation work was to identify and develop a
suitable volumetric gel for MR-IGRT and to demonstrate the proof of concept of applying the gel to
MR-IGRT systems, the signal intensities from T1-weighted images were used rather than acquiring a
long series of MR images to quantitatively calculate R1 or T1 values. As previously mentioned, both
the linear relationships between R1 and radiation dose and MR signal intensity (arbitrary unit) and
radiation dose have been reported for iron-based Fricke-type gels [78–81]. The iron-containing Fricke
gels also produce a multi-exponential change in spin-spin relaxation rate R2 (=1/T2 where T2 is the
transverse decay time) to radiation; the R2 responses of Fricke gels are not typically used for radiation
dose assessment due to this more complex and smaller magnitude relationship [82]. The signal intensity
of an MR image is proportional with the following relationship:
𝑆 ∝ 𝑒

𝑡
−( )
𝑇2

(15)

where S is the signal intensity, t is time, and T2 is such that the signal decreases to 37% (or e-1) of its
initial value. The more complex quantification of R2 in comparison with dose for Fricke gels required
dividing the relaxation rate behaviors into multiple parameters since multiple proton species (bulk
water, bound water, tightly bound proton species, and other gel attributed hydroxyl groups) were
required to explain this relaxation in Fricke gels [82]. The original Fricke gels have been modified with
the addition of reporter compounds, most notably xylenol orange, producing Fricke xylenol orange gels
(FXG), and exploration of gel matrixes outside of gelatin [63, 67, 83–85]. Reporter compounds or
chelators are organic chemicals that form two or more coordination bonds with iron ions and improve
the stability of spatial dose distribution by reducing the diffusion of iron ions. Historically, the main
limitation of the Fricke-type gels was the diffusion of the small iron ions in the gel post-irradiation,
degrading the dose distribution, even with the addition of reporter compounds.
Polymer gels date back to at least 1954 with Alexander’s use of polymethylmethacrylate [61].
Whereas Fricke-type radiochromic gels depend on the conversion of iron ions, polymer gels depend on

10
the crosslinking of monomers forming polymers induced by free radicals produced by the radiolysis of
water [86–89]. The polymer gel BANG® (N,N’ – methylene – bis – acrylamide (BIS), acrylamide,
nitrogen, and gelatin) dosimeter has been simulated in the Viewray system to show good agreement
between Pinnacle treatment planning system calculated doses and simulated 3D doses from the
BANG® gel [59]. The measured 3D doses from BANG® and other polymer gels are dependent on
spin-spin relaxation rate R2 (=1/T2) radiation-induced changes due to polymerization of monomers
inside the gel [88]. However, polymer gels require toxic chemicals and an oxygen free environment
and have demonstrated energy and dose rate dependence as well as other undesirable characteristics
[88, 90–95].
Unlike both the radiochromic and polymer gels, radiochromic plastics do not depend on the
radiolysis of water. This most recent class of 3D dosimeters first presented in 2003 consists of a nonwater soluble leuco-dye that is dissolved in a halogenated hydrocarbon, such as chloroform, and
contained in a polyurethane plastic or silicone matrix [96–100]. Instead of water, radiochromic plastic
dosimeters depend on the free radical byproducts of the radiolysis of halogenated hydrocarbons,
resulting in the oxidation of the leuco dyes. Radiochromic plastic dosimeters do not require a container
but cannot be imaged using MRI. Radiochromic plastic dosimeters require an optical read-out technique
such as an optical computed tomography (optical-CT) device [89, 101–107]. While radiochromic
plastic dosimeters cannot be read-out using MRI, their preservation of signal with minimal diffusion
has allowed for remote dosimetry of the Viewray system demonstrating agreement with generated plans
[108–110].
Previously, Fricke-type dosimeters were not favored for clinical quality assurance practices
due to a faster rate of diffusion compared to polymer gels. However, with the MR-Linac and other MRIGRT systems, Fricke-type dosimeters can now be imaged in real-time during irradiation and
immediately post-irradiation without moving the dosimeters to a separate MRI or optical scanner [111–
114]. Fricke-type gels are easier to make in-house compared to polymer gels, which require a hypoxic
environment and toxic chemicals. While Fricke-type gels cannot be completely containerless like
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radiochromic plastic dosimeters (which have no MR-visible response), they can fill any shaped molds
allowing for the possible inclusion of heterogeneous components. As a result, this dissertation revisited
Fricke-type dosimeters for MR-IGRT applications. And as mentioned previously, since the goal of this
dissertation work was to identify and develop a suitable volumetric gel for MR-IGRT and to
demonstrate the proof of concept of applying the gel to MR-IGRT systems, the signal intensities from
T1-weighted images were used rather than acquiring a long series of MR images to quantitatively
calculate R1 or T1 values.

1.3 Outline of the dissertation
The purpose of this dissertation was to investigate volumetric, MR-visible, and radio-sensitive
detectors for dosimetry and quality assurance for integrated MR radiation therapy systems. The MRIGRT system used for this dissertation was the 1.5 T – 7 MV Elekta MR-Linac. However, the work in
this dissertation are relevant and can be translated to any other existing MR-IGRT system.
Chapter 2 investigates candidate volumetric gel formulations, both those already presented in
the literature and novel formulations explored for this dissertation, for dosimetric value on MR-IGRT
systems. This dissertation solely investigated radiochromic type volumetric dosimeters and primarily
those based on iron. The optimal formulation for MR-IGRT applications was identified.
Chapter 3 presents the characterization of the optimal radiochromic gel formulation identified
in Chapter 2. Dose linearity, radiological properties, reproducibility, time stability, energy dependence,
reusability of a formulation, dose rate dependence, fractionation dependence, gel matrix dependence,
and diffusion were quantified.
Chapter 4 investigates strong magnetic field and gradient field/radiofrequency effects on the
response of the optimal radiochromic gel formulation as well as optimization of MR sequences for the
purposes of real-time imaging during irradiation and immediate post-irradiation imaging for volumetric
dose quantification. Other MR considerations that are true for any MRI read-out technique, such as
MRI artifacts, are also discussed.
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Chapter 5 examines the performance of the optimal radiochromic gel formulation as an endto-end quality assurance device both in heterogeneous and homogeneous phantoms for 3D plans and
step-and-shoot intensity-modulated radiation therapy (IMRT) commissioning plans. Irradiations were
completed alongside the quasi-3D ArcCHECK-MR QA system.
A summary and general discussion of the unique contributions of this work are presented in
Chapter 6.
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Chapter 2 – Comparison of radiochromic systems for MR-IGRT applications

2.1 Rationale
With the advent of MR-IGRT systems, interest in 3D gel dosimeters has grown [108–126]. In
particular, polymer gels have gained popularity over radiochromic gels due to the high diffusion rate
of radiochromic gels. With the new possibility for real-time and immediate post-irradiation MRI in an
MR-IGRT system, I revisited already existing radiochromic gel formulations and proposed new ones
created in-house for MR-IGRT applications. Due to the timeline of this dissertation, some irradiations
were conducted in clinical conventional linacs, using a Cobalt-60 (Co-60) source, or an orthovoltage
x-ray unit (Philips RT-250) when the Elekta MR-Linac was not available. All irradiations in the MRLinac were conducted following an initial calibration of the MR-Linac. Consequently, the doses given
are approximate but are within 5% of the dose determined at a subsequent full calibration. Calibration
of the MR-Linac was done following IAEA TRS-398 guidelines [127]. TRS-398 used the tissue
maximum ratio (TMR), a special case of tissue phantom ratio (TPR), with a source to axis distance
(SAD) set-up unlike the requirement of percent depth dose (PDD) measurements with a source to
surface distance (SSD) set-up in the AAPM TG-51 protocol. The use of TMR was preferred over PDD
due to the preservation of the ratio of dose per incident photon at 10 cm and 20 cm depths with and
without a 1.5 T B0 field whereas the PDD curve behavior is different in a 1.5 T B0 field (maximum dose
is at a shallower depth than with no B0 field for example) [55]. The calibration of the MR-Linac was
conducted using an MR-compatible Standard Imaging Exradin A1SL ionization chamber and crossverified using a PTW Farmer chamber with both measurements in modified MR-compatible water
tanks. For this dissertation work on relative dosimetry, the exact dose is not necessary to demonstrate
the proof of concept of dose-response and other characteristics. For all irradiations, a control sample of
each dosimeter was either an un-irradiated region of the dosimeter or an un-irradiated cuvette that was
exposed to the same environment as the irradiated samples (except for receiving radiation).

14

2.2 Iron(II) oxidation gel formulations
Based on the conventional FXG formulation, three additional iron(II) sources were compared
with the conventional FAS iron(II) source to determine differences in optical and MR contrast.

2.2.1 Dosimeter fabrication
Radiochromic dosimeters consist of a radiochromic reporter component, free radical source,
solvent, iron source, and a gelling agent. Four iron(II) oxidation gel formulations were investigated,
referred to as FXG, FOX (ferrous oxide – xylenol orange), FCX (ferrous chloride – xylenol orange),
and FPX (ferrous phthalocyanine – xylenol orange) with the compositions outlined below. Iron(III)
binds to xylenol orange (reporter component) with a 1:1 ratio forming a purple complex. To improve
uniform mixing, the iron source was added to the solvent before the reporter component. All samples
were prepared in a low-light area to prevent extraneous environmental exposure prior to irradiation. All
gel samples were prepared approximately 24 hours prior to irradiation to allow for gel solidification.
The conventional FXG formulation consisted of xylenol orange disodium salt, deionized water,
and ammonium iron(II) sulfate hexahydrate (or ferrous ammonium sulfate) (Sigma-Aldrich) (Table 1).
The FXG formulation was modified from the original Fricke formulation by adding xylenol orange and
was included as a comparison to the other three newly developed formulations [60, 84]. A small amount
of sulfuric acid (Sigma-Aldrich) was added to stabilize the formulation. The FXG formulation in gel
was prepared using 300 bloom gelatin from porcine skin. 75-80% of the total water volume was used
to first dissolve gelatin. The gelatin mixture was heated to at least 40 ºC then cooled to 25 ºC prior to
adding the concentrated chemical solution containing the reporter component and iron source. The gels
were then stored at 4 ºC then acclimated to room temperature prior to irradiation.
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Table 1: Chemical components of FXG formulation.
Component
Xylenol orange disodium salt
Water
Ammonium iron(II) sulfate hexahydrate
Sulfuric acid
H2SO4
Gelatin

Chemical formula
C31H30N2Na2O13S
H2O
(NH4)2[Fe(SO4)2]•6H2O
50 mM
(C17H32H5O6)x

Concentration
0.05 mM
~96 wt %
1 mM
4 wt %

The FOX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized
water, and iron(II) oxide (Sigma-Aldrich) (Table 2). The same gel procedures described for FXG were
used for the FOX, FCX, and FPX formulations.
Table 2: Chemical components of FOX formulation.
Component
Xylenol orange disodium salt
Water
Iron(II) oxide
Sulfuric acid
Gelatin

Chemical formula
C31H30N2Na2O13S
H2O
FeO
H2SO4
(C17H32H5O6)x

Concentration
0.05 mM
~96 wt %
1 mM
50 mM
4 wt %

The FCX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized
water, and iron(II) chloride (Sigma-Aldrich) (Table 3).
Table 3: Chemical components of FCX formulation.
Component
Xylenol orange disodium salt
Water
Iron(II) chloride
Sulfuric acid
Gelatin

Chemical formula
C31H30N2Na2O13S
H2O
FeCl3
H2SO4
(C17H32H5O6)x

Concentration
0.05 mM
~96 wt %
1 mM
50 mM
4 wt %

The FPX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized
water, and iron(II) phthalocyanine (Sigma-Aldrich) (Table 4).
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Table 4: Chemical components of FPX formulation.
Component
Xylenol orange disodium salt
Water
Iron(II) phthalocyanine
Sulfuric acid
Gelatin

Chemical formula
C31H30N2Na2O13S
H2O
C32H16FeN8
H2SO4
(C17H32H5O6)x

Concentration
0.05 mM
~96 wt %
0.1 mM
50 mM
4 wt %

2.2.2 Optical methods
Samples of gel were prepared in standard size cuvettes with an optical path length of 1 cm
(Fisher Scientific) for optical read-out. The optical density (OD, unit cm-1, as explained above in
Chapter 1 as absorbance/sample length in equation (10)) of the gel was read-out with wavelengths in
the visible range of the spectrum using a GENESYS™ 10S UV-VIS spectrophotometer (Thermo
Scientific). The spectrophotometer outputs an absorbance value, and with the use of 1 cm dimension
standard cuvettes, absorbance can directly be related to OD as absorbance = OD (cm-1). The net OD
was calculated by subtracting the OD value of un-irradiated samples from that of irradiated samples for
each wavelength. The standard deviation of repeat spectrophotometer measurements for a single
cuvette was no more than 0.004 OD with up to 30 repeat readings, as will be shown in Chapter 3 (Figure
27). While the overall goal of this dissertation was for MR-IGRT applications, access to the MR-Linac
was not available at the beginning of this work, and access to a clinical MRI system was not possible
within the timeframe of irradiations using clinical radiation therapy machines. Also, the standard
deviation of 30 consecutive spectrophotometer measurements was no more than ±0.5% of the mean
OD, a much smaller uncertainty than might be expected from measurements of MR signal intensity (up
to ±10% standard deviation from the mean MR signal). For these reasons, any investigations that
required low signal read-out uncertainty to assess the performance of the dosimeter used optical
absorbance measurements instead of MR signal intensities (for example, B0 field dependence and others
later described in Chapter 3).
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2.2.3 Magnetic resonance methods
All gels were contained in polyethylene terephthalate (PET) plastic containers (PAPER
MART™) for irradiation and MR imaging. For the iron comparison portion of the study, all gels were
contained in a 45 mm diameter cylindrical PET container.
The radiation isocenter and MR isocenter of the pre-clinical MR-Linac system are located
143.5 cm from the linac target and are approximately 14.3 cm above the surface of the couch (the couch
has no vertical motion in the pre-clinical system). The center of each gel was positioned close to
isocenter distance (within 5 mm). For the iron comparison portion of the study, the 45 mm diameter
gels were positioned on top of 12.2 cm of water-equivalent plastic backscatter material. No build-up
material was added on top of the gels since measurements were taken at the central cross-section of the
gels and this was an initial investigation to compare radiation sensitivities. These gels were imaged
with a balanced fast field echo (bFFE) sequence of repetition time/echo time (TR/TE) = 5/2.4 ms during
irradiation and a T1-weighted turbo spin echo (TSE) sequence of TR/TE = 500/20 ms pre-irradiation
and post-irradiation. The real-time temporal resolution was 275 ms for a single slice per acquisition.
All images were acquired with 5 mm slice thickness using a body coil. For all of the real-time 2D MR
images, a resolution of 1.17 pixels per mm with pixel size of 0.86 x 0.86 mm2 and field of view of
328.56 x 328.56 mm2 were used.

2.2.3 Iron(II) oxidation results and discussion
The physical dosimeters, snapshot of the real-time acquisition, and post-irradiation
(approximately 17 Gy) images of the four iron compounds investigated (A – FOX, B – FCX, C – FPX,
and D – FXG) are shown in Figure 3.
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Figure 3: a) Pictures of physical dosimeters where A – FOX, B – FCX, C – FPX, and D – FXG. The
top half of each gel was not irradiated, and the bottom half was irradiated to approximately 17 Gy. b)
Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with TSE
TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast.

As shown in Figure 3, B – FCX and D – conventional FXG responded to irradiation, both
optically and MRI. In contrast, C – FPX showed minimal MR change after irradiation. The real-time
net change in MR signal is shown in Figure 4. The relative MR signal intensity was plotted from a
region of interest taken within the irradiated region of each dosimeter, demonstrating a near-linear
change with dose delivered constantly over time (R2 = 0.93 to 0.97). The relative MR signal intensity
was calculated for each dosimeter by dividing all net signal intensities (irradiated signal intensity – un-
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irradiated signal intensity) by the net signal intensity at the time beam was turned off (225 s). The error
bars in Figure 4 represent the propagated standard deviation from the regions of interest measured
within the irradiated region and outside the irradiated region in each dosimeter.

Figure 4: Relative MR signal intensities during real-time acquisition of a) FOX, b) FCX, c) FPX, and
d) FXG. The orange shaded regions indicate beam-on times. Linear fits in the beam-on sections are
also indicated. The error bars in Figure 4 represent the propagated standard deviation from the
regions of interest measured within the irradiated region and outside the irradiated region in each
dosimeter.
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Unlike visual inspection of the gels’ optical and MRI response, real-time relative MR signal
intensity plots demonstrated that a) FOX and d) conventional FXG were similar in terms of slope and
linearity. Again, c) FPX showed minimal MR change during and after irradiation (slope during
irradiation was -0.0005 relative MR signal intensity/time). The significant result of this first
demonstration of 2D real-time dose acquisition with iron-based gels (except for c) FPX) in the MRLinac was that the real-time relative MR signal intensity change was linear with respect to time and
therefore dose with a constant dose rate of approximately 540 ± 10 cGy/minute (R2 = 0.928, 0.967, and
0.962 for a) FOX, b) FCX, and d) FXG, respectively). This result indicated that the conversion of
iron(II) to iron(III) due to free radicals produced from irradiation of water molecules occured quickly
enough to capture their production in real-time in MR-IGRT systems [62]. The overall net percent
signal intensity increases in real-time were 24.4±10%, 21.0±5%, 3.1±5%, and 22.2±6% for a) FOX, b)
FCX, c) FPX, and d) FXG, respectively (Figure 4). The net percent signal intensity increases from the
post-irradiation T1-weighted images were 47.1±2%, 32.7±1%, 6.3±1%, and 32.2±1% for a) FOX, b)
FCX, c) FPX, and d) FXG, respectively (Figure 3).
FOX and FXG were further compared optically after irradiations using a Co-60 source (Figure
5). The Co-60 doses were calculated accounting for exponential decay of the source and PDD using
BJR Supplement 25 depending on the SSD, depth of measurement, and field size [128]. Complete
spectra were acquired for several different dose levels, and the dose responses at each of the two peaks
observed with both gels were evaluated. The optical results for FOX and FXG again agreed that FOX
was more sensitive to megavoltage irradiation when compared to FXG at both of their respective
spectral peaks. The optical calibration curves for FOX and FXG were fit linearly (R2 = 0.98 to 1.00) at
their spectral peaks of 430 nm and 585 nm for FOX and 445 nm and 585 nm for FXG. Since the control
measurements of 0 Gy were included in the linear fit calculation, the fits were not forced to intercept at
0. 430 nm and 445 nm are both near the wavelengths absorbed for an observed color of yellow. 585 nm
is near the wavelengths absorbed for an observed color of purple. As the irradiated dosimeters undergo
an optical color change from yellow to purple after iron(III) forms a complex with xylenol orange, the
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contribution of yellow decreases while the contribution of purple increases (therefore the signal at 430
nm and at 445 nm for FOX and FXG, respectively, decrease while the opposite is true at 585 nm). The
optical spectra and spectral peaks differ between FOX and FXG due to their different chemical
contributions of iron, resulting in differences in the absorbance of light. The calibration curves for FOX
were 114% and 54% greater for the yellow and purple spectral peaks, respectively, compared to FXG.
The error bars in the calibration curves were smaller than the symbols and represented the standard
deviation of three spectrophotometer readings per sample. Uncertainties due to batch (within and
between) variabilities were further investigated for FOX only in Chapter 3 (Figure 26).

Figure 5: Optical response of FOX and FXG. a) Spectral response of FOX, b) linear optical response
of FOX at spectral peaks of 430 nm and 585 nm (R2 = 0.9944 and 0.9978, respectively), c) spectral
response of FXG, and d) linear optical response of FXG at spectral peaks of 445 nm and 585 nm (R2
= 0.9930 and 0.9844, respectively). The error bars in the calibration curves were smaller than the
symbols and represented the standard deviation of three spectrophotometer readings per sample.

The overall comparison of the four iron types demonstrated that the FOX formulation was the
best candidate from the iron(II) oxidation formulations for future MR-IGRT studies. The FOX
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formulation demonstrated greater optical and MR contrast when compared to the other iron(II)
oxidation formulations (up to 114% greater optical response, 10% greater real-time MR response, and
46% greater post-irradiation T1-weighted MR response when compared to conventional FXG).
All of the above iron(II) oxidation formulations were then tested using sodium thiocyanate as
the reporter compound instead of xylenol orange to investigate changes in optical and MR contrast.
These four iron(II) oxidation gel formulations were referred to as FASST (ferrous ammonium sulfate
– sodium thiocyanate), FOST (ferrous oxide – sodium thiocyanate), FCST (ferrous chloride – sodium
thiocyanate), and FPST (ferrous phthalocyanine – sodium thiocyanate) with the compositions the same
as FXG, FOX, FCX, and FPX except for replacing 0.05 mM xylenol orange with 1.0 mM sodium
thiocyanate. Sodium thiocyanate formed a red complex in the presence of iron(III) due to the formation
of [Fe(SCN) · (H2O)5]2+ while remaining colorless clear in the presence of iron(II) (Figure 6).

Figure 6: Sample of FCST in solution (without gelatin) with a) un-irradiated iron(II)-containing
sample and b) approximately 40 Gy irradiated iron(III)-containing sample using Co-60 source
showing color change from a) colorless to b) blood red characteristic of thiocyanate indicators in the
presence of iron(III).

Unlike xylenol orange, using sodium thiocyanate did not result in any MR changes when
irradiated to the same doses, suggesting that the sensitivity of this formulation was inadequate for
conventional radiation therapy dosimetry (Figure 7). The optical changes were also minimal for this
dose range, so again, the FOX formulation remained the ideal candidate for further MR-IGRT
applications. The net percent signal intensity increases from the post-irradiation T1-weighted images
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were 6.1±2%, 6.9±1%, 4.6±2%, and 6.0±2% for a) FOST, b) FCST, c) FPST, and d) FASST,
respectively. In the future, other thiocyanate compounds and their interactions with gelling agents could
be investigated for improved optical and MR changes post-irradiation.

Figure 7: a) Pictures of physical dosimeters where A – FOST, B – FCST, C – FPST, and D – FASST.
The top half of each gel was not irradiated, and the bottom half was irradiated to approximately 17
Gy. b) Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with
TSE TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast.

2.3 Iron(III) reduction gel formulations
The rationale for investigating iron(III) reduction gel formulations was due to the instability of
iron(II) oxidation gels (such as shown by the already oxidized purple FXG and FCX gels prior to
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irradiation) (Figure 3) and due to previous studies suggesting slower diffusion [129, 130]. The overall
iron(III) reduction gel fabrication, irradiation set-up, and MRI techniques were the same as those listed
above for the iron(II) oxidation gel formulations. One already existing iron(III) reduction formulation
was assessed (Turnbull blue (TBG)) along with two additional iron(III) sources.
The TBG formulation was created based on photography film processing reactions [131–133].
The Turnbull blue or Prussian blue color was formed during the cyanotype process first invented by
John Frederick William Herschel. The TBG formulation consists of potassium ferricyanide, iron(III)
chloride, and iron(III) ammonium citrate. After irradiation, organic free radicals are created and reduce
iron(III) to iron(II), which then interact with potassium ferricyanide (red prussiate of iron), ultimately
forming the dye Turnbull blue or Prussian blue by following two possible pathways:
Fe3+ + ℎ𝑣, H2 O → Fe2+

(7)

Fe2+ + [𝐹𝑒(𝐶𝑁)6 ]3− → 𝑭𝒆[𝑭𝒆(𝑪𝑵)𝟔 ]−

(8)

[𝐹𝑒(𝐶𝑁)6 ]3− + ℎ𝑣, H2 O → [𝐹𝑒(𝐶𝑁)6 ]4−

(9)

Fe3+ + [𝐹𝑒(𝐶𝑁)6 ]4− → 𝑭𝒆[𝑭𝒆(𝑪𝑵)𝟔 ]−

(10)

with the iron(III) components in orange and the iron(II) components in blue and the Turnbull blue
Fe[Fe(CN)6]- product in bold font.
Several different combinations of concentrations of the chemical components in TBG were
presented by previous studies, and the formulation listed in Table 5 was found to be the most sensitive
to megavoltage irradiation [129, 130, 134, 135]. Initial investigations of TBG were done in solution
(no gelling agent).
Table 5: Chemical components of TBG formulation.
Component
Potassium ferricyanide
Iron(III) chloride
Iron(III) ammonium citrate
Water
Hydrochloric acid
Gelatin

Chemical formula
K3Fe(CN)6
FeCl3
C6H807 · FeNH3
H2O
HCl
(C17H32H5O6)x

Concentration
1.5 mM
0.45 mM
1.5 mM
~97-100 wt %
5 mM
0-3 wt %
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The FT (ferric chloride – triphenylamine) formulation consisted of iron(III) chloride (SigmaAldrich), triphenylamine (Sigma-Aldrich), and chloroform (Sigma-Aldrich) (Table 6). The FT
formulation was only investigated in solution form due to using chloroform as the solvent. Future work
could investigate the FT formulation in micelle form in a gelatin-based gel. After iron(III) is converted
to iron(II), it forms a complex with triphenylamine that appears green.
Table 6: Chemical components of FT formulation.
Component
Iron(III) chloride
Triphenylamine
Chloroform
Hydrochloric acid

Chemical formula
FeCl3
(C6H5)3N
CHCl3
HCl

Concentration
2 mM
81 mM
~100 wt %
276 mM

The FO (ferric ammonium oxalate – o-phenanthroline) formulation consisted of iron(III)
ammonium oxalate trihydrate (Sigma-Aldrich), o-phenanthroline or 1,10-phenanthroline (SigmaAldrich), and water (Table 7). o-phenanthroline must first be dissolved in ethanol before combining
with the other chemical components. After iron(III) is converted to iron(II), it forms a complex with ophenanthroline that appears red with a 1:3 ratio.
Table 7: Chemical components of FO formulation.
Component
Iron(III) ammonium oxalate
trihydrate
o-phenanthroline
Ethanol
Water
Sulfuric acid
Gelatin

Chemical formula
(NH4)3[Fe(C2O4)3]
· 3H2O
C6H807 · FeNH3
C2H6O
H2O
H2SO4
(C17H32H5O6)x

Concentration
28 mM
26 mM
5 wt %
~91 wt %
17 mM
4 wt %

2.3.2 Iron(III) reduction results and discussion
The TBG formulation responded linearly optically (OD) with respect to Co-60 dose at its
spectral peak of 690 nm. 690 nm is within the absorbed wavelength range for an observed color of
green/blue. However, this optical response was not immediately linear and took at least 72 hours to
develop (Figure 8). The appearance of an offset in the dose response curve even after 72 hours may be
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due to a gradual darkening of the gel with time following preparation, rather than a nonlinearity of
response at low dose levels. The error bars in the calibration curve were smaller than the symbols and
represented the standard deviation of three spectrophotometer readings per sample.
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Figure 8: Post-irradiation response of TBG in solution (no gelatin). a) Pictures of TBG irradiated to
0, 5, 10, 20, 40, and 60 Gy using a Co-60 source immediately post-irradiation, 3 hours postirradiation, and 72 hours post-irradiation. b) Spectral response of TBG 72 hours after irradiation. c)
Calibration curve of TBG 72 hours after irradiation at the spectral peak 690 nm. The error bars in
the calibration curve were smaller than the symbols and represented the standard deviation of three
spectrophotometer readings per sample.
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The TBG formulation was then tested in the MR-Linac in 2 wt % and 3 wt % gelatin to
investigate whether any MR contrast could be detected after approximately 30 Gy (Figure 9). TBG in
2 wt % gelatin showed an increase in MR signal intensity of approximately 0.6% post-irradiation of
approximately 30 Gy. TBG in 3 wt % gelatin showed an increase in MR signal intensity of
approximately 5.1% after absorbing the same dose of 30 Gy. Due to the delayed optical dose response
over time (Figure 8) and the minimal MR changes post-irradiation (Figure 9), the TBG formulation
was not further investigated for MR-IGRT applications.

Figure 9: MR images of TBG. a) TBG in 2 wt % gelatin pre-irradiation, b) TBG in 2 wt % gelatin
post-irradiation of approximately 30 Gy, c) TBG in 3 wt % gelatin pre-irradiation, and d) TBG in 3
wt % gelatin post-irradiation of approximately 30 Gy.

While the TBG formulation was not found to be useful for MR-IGRT applications, future
investigations of TBG could involve incorporating it into gel matrixes other than gelatin as an
ultraviolet (UV) light dosimeter (Figure 10). A preliminary evaluation of the response of TBG to UV
exposure demonstrated that a visible optical response took place following exposure when incorporated
into different matrixes (sodium polyacrylate ball and powder and Encapso® K rubber) (Figure 10).
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Figure 10: a) TBG incorporated into sodium polyacrylate ball prior to UV exposure, b) TBG post UV
exposure, c) TBG incorporated into sodium polyacrylate powder prior to UV exposure, d) TBG post
UV exposure, e) TBG incorporated into Encapso® K rubber prior to UV exposure, f) TBG post UV
exposure, g) side view of e, and h) side view of f.

Similar to the TBG formulation, the FT formulation was also found to have a delayed linear
optical response to irradiation. Unlike TBG, FT’s spectral response had three peaks (407 nm, 485 nm,
and 650 nm). 407 nm is bordering the ultraviolet light absorption wavelength range and therefore cannot
necessarily be correlated to optical observed color. 485 nm is in the absorbed wavelength range for an
observed color of yellow/orange, and 650 nm is in the absorbed wavelength range for an observed color
of green/blue. The calibration curve is plotted below for the spectral peak of 650 nm with a near-linear
fit with R2 = 0.98 (Figure 11) The error bars in the calibration curve were smaller than the symbols and
represented the standard deviation of three spectrophotometer readings per sample.
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Figure 11: Post-irradiation response of FT in solution. a) Pictures of FT irradiated to 0, 5, 10, 20,
40, and 60 Gy using a Co-60 source immediately post-irradiation, 3 hours post-irradiation, 48 hours
post-irradiation, and 96 hours post-irradiation. b) Spectral response of FT 96 hours after irradiation.
c) Calibration curve of FT 96 hours after irradiation at the spectral peak 650 nm. The error bars in
the calibration curve were smaller than the symbols and represented the standard deviation of three
spectrophotometer readings per sample.
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Since FT was found to have a delayed optical response and could not easily be incorporated
into a gel matrix, it was not further investigated for MR contrast. However, future investigations of FT
could involve incorporating it into other matrixes as an ultraviolet light dosimeter (Figure 12).

Figure 12: a) FT in solution showing color change from colorless clear to dark green with increasing
UV exposure, b) FT incorporated into Encapso® K rubber prior to UV exposure, c) FT post UV
exposure (yellow color change), d) side view of b, and e) side view of c.

Unlike the TBG and FT formulations, the FO formulation was found to give an immediate
linear optical response post-irradiation up to at least 100 Gy at its spectral peak of 512 nm (Figure 13).
512 nm is within the absorbed wavelength range for an observed color of red. Since one of polymer
gel’s main disadvantages was its oxygen dependence, the oxygen dependence of FO was investigated
along with its dose rate dependence, shelf-life time, and gelatin percentage dependence on sensitivity.
In order to test oxygen dependence, FO in solution was degassed with N2 for 10 minutes per sample to
remove dissolved O2 (Figure 14). While the exact concentration of O2 was not measured after degassing,
the bubbling of a chemically inert gas (such as N2 used in this case) can remove dissolved gases such
as O2 from solution (degasification is also commonly called sparging in chemistry). After removal of
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O2, the sensitivity of FO to irradiation was increased about 6.0%. Deoxygenation of PRESAGE® was
found to increase the sensitivity by approximately 30% whereas deoxygenation of FXG was found to
decrease the sensitivity [136, 137]. The linearity of the dose response was not affected for FO or for
PRESAGE® and FXG in the literature. The error bars in the calibration curves in Figure 13 and Figure
14 represented the standard deviation of spectrophotometer measurements averaged for three cuvettes
per dose level.

Figure 13: a) Spectral response of FO immediately after irradiation (inset image shows FO before
irradiation – yellow and after irradiation – red). c) Calibration curve of FO at the spectral peak 650
nm. The error bars in the calibration curve represented the standard deviation of spectrophotometer
measurements averaged for three cuvettes per dose level.
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Figure 14: Oxygen dependence test of FO in solution by O2 degassing with N2 for 10 minutes. a)
Calibration curves of FO with and without O2 and b) example set-up for degassing with N2 into the
solution with a vent (actual set-up was covered to prevent light affecting the samples). The error bars
in the calibration curves represented the standard deviation of spectrophotometer measurements
averaged for three cuvettes per dose level.

The dose rate dependence of FO was tested using a Co-60 source at different distances from
the source (Figure 15). The dose rate was approximated relative to distance from the source using the
inverse square law (dose rate2 = dose rate1 * (distance1/distance2)2), so the dose rate at 100 cm source
to surface distance (SSD) was 0.64 of the dose rate at 80 cm SSD. The error bars in the calibration
curves in Figure 15 represented the standard deviation of spectrophotometer measurements averaged
for three cuvettes per dose level.
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Figure 15: Dose rate dependence of FO. The error bars in the calibration curve represented the
standard deviation of spectrophotometer measurements averaged for three cuvettes per dose level.

The shelf-life of FO and its effect on dose response sensitivity was tested in light-tight
environments both at room temperature (RT) and at 4 ºC (Figure 16). After 1 week of storage, the
calibration curves after irradiation were 2.3% and 0.8% decreased in slope for RT and 4 ºC,
respectively, when compared to immediate preparation of FO prior to irradiation. After 2 weeks of
storage, the calibration curves after irradiation were 4.6% and 2.1% decreased in slope for RT and 4
ºC, respectively, when compared to immediate preparation of FO prior to irradiation. Future work
should include batch uncertainties to better quantify the uncertainties in the changes of these calibration
curves. The calibration curves decreased in slope more for RT than for 4 ºC after both 1 week and 2
weeks of storage. The calibration curves decreased in slope, regardless of storage temperature, when
compared to immediate preparation prior to irradiation.
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Figure 16: a) Calibration curves of FO in solution (no gelatin) after storage at room temperature
(RT) and 4 ºC (4C) for 1 week compared to immediately prior to irradiation and b) after storage for 2
weeks. The error bars in the calibration curves represented the standard deviation of
spectrophotometer measurements averaged for three cuvettes per dose level.

The dependence of sensitivity of FO on gelatin concentration was then investigated between
1.5 and 5 wt %. Greater gelatin concentrations increased the background OD of samples prior to
irradiations (Figure 17). The post-irradiation sensitivities were most similar for 1.5 and 2 wt % and for
3 and 5 wt % gelatin. The overall calibration curve slopes decreased with increasing gelatin
concentration, which agreed with the literature for FXG [137].
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Figure 17: Gelatin percentage dependence on FO sensitivity (inset image shows differences in OD of
samples prior to irradiations depending on gelatin percentage). The error bars in the calibration
curves represented the standard deviation of spectrophotometer measurements averaged for three
cuvettes per dose level.

After characterizing the FO formulation for optical linearity with radiation dose, oxygen
dependence, dose rate dependence, shelf-life, and gelatin percentage dependence with no effects on the
linearity of the response for all the above, FO was then imaged with MRI in the MR-Linac. Alongside
FO, the following combinations were investigated for MR contrast (Table 8). 2,2’-Bipyridine was a
similar reporter component to o-phenanthroline that also formed complexes with iron(II) resulting in a
red color post-irradiation.
Table 8: Iron(III) combinations for investigation in the MR-Linac.
Iron(III) component
Iron(III) ammonium oxalate trihydrate
Iron(III) citrate
Iron(III) ammonium oxalate trihydrate
Iron(III) citrate

Reporter component
o-phenanthroline
o-phenanthroline
2,2’-Bipyridine
2,2’-Bipyridine

Name of formulation
FO
FCO
FB
FCB

However, similar to TBG, FO also did not result in a clearly distinguishable MR signal intensity
change post-irradiation of approximately 34 Gy (Figure 18). The net percent signal intensity increases
from the post-irradiation T1-weighted images were 8.8±1%, 11.0±1%, 8.1±1%, and 8.8±2% for a) FO,
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b) FCO, c) FB, and d) FCB, respectively. Similarly to TBG and FT, future investigations of FO could
involve incorporating it into other matrixes as an ultraviolet light dosimeter (Figure 19).

Figure 18: a) Pictures of physical dosimeters where A – FO, B – FCO, C – FB, and D – FCB. The
top half of each gel was not irradiated, and the bottom half was irradiated to approximately 34 Gy. b)
Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with TSE
TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast.
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Figure 19: a) FO incorporated into Encapso® K rubber prior to UV exposure, b) FO post UV
exposure (red color change), c) side view of a, and d) side view of b.

2.4 Summary
After comparisons of iron(II) and iron(III) formulations optically and with MRI, the iron(II)
formulation FOX had the greatest optical and MR contrast. FOX changed linearly with respect to dose
for both optical and MR read-out, both immediately post-irradiation and in real-time during irradiation.
Whereas iron(III) formulations, such as FO, responded linearly with respect to dose up to at least 100
Gy, its response could not be accurately measured using MRI at clinically relevant quality assurance
dose levels. Overall, iron(II) formulations are recommended for MR-IGRT applications, and iron(III)
formulations are recommended for UV applications (preliminary results shown in Figure 10, Figure 12,
and Figure 19). Further characterization of FOX is presented in Chapter 3.
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Chapter 3 – Characterization of optimal radiochromic formulation

3.1 Rationale
Following identification of the most ideal candidate gel formulation for MR-IGRT applications
in Chapter 2, the FOX and a reusable version of FOX (rFOX) formulations were characterized for their
dose response. Since FOX depends on the oxidation of iron(II) after the radiolysis of water, rFOX was
created with the addition of a reducing agent. Further explanation on the behavior of rFOX with respect
to the reducing agent is presented in this chapter. Most importantly, for volumetric dose comparisons
with planned dose presented in Chapter 5, the linearity of the dose response should be preserved
regardless of the irradiation scenario to allow for linear scaling of MR signal intensity to relative dose.
The dose linearity, radiological properties, reproducibility, time stability, energy dependence,
reusability of rFOX, dose rate dependence, fractionation dependence, gel matrix dependence, and
diffusion are presented in this chapter.

3.2 Dose linearity
As was mentioned in Chapter 2, dose linearity of FOX were important characteristics for
eventual relative scaled dose comparisons with treatment planning system planned doses. A more
detailed characterization of the linearity of FOX and rFOX are presented in this chapter.

3.2.1 Optical linearity
FOX is linear with radiation dose optically at its spectral peaks of 440 nm and 585 nm up to
approximately 15 Gy and plateaus above 30 Gy up to at least 100 Gy (Figure 20). The error bars in the
calibration curves represented the standard deviation of spectrophotometer measurements averaged for
three cuvettes per dose level.
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Figure 20: a) Representative absorption spectra of un-irradiated and irradiated FOX, b) unirradiated yellow FOX on the left and irradiated purple FOX on the right, c) background subtracted
spectrum with peaks at 440 nm and 585 nm, d) calibration curve at 440 nm, and e) calibration curve
at 585 nm. The error bars in the calibration curves represented the standard deviation of
spectrophotometer measurements averaged for three cuvettes per dose level.

Initial optical testing for rFOX was conducted using a clinical orthovoltage unit since
immediate optical readings were not possible using the MR-Linac (and rFOX’s signal decay had not
yet been carefully investigated for optical read-out). Similarly to previous irradiation using a Co-60
source, orthovoltage doses were calculated using PDD tables in BJR Supplement 25[138]. Doses up to
approximately 20 Gy were delivered to rFOX containing different levels of reducing agent (RA) that
was responsible for making rFOX reusable (1 wt %, 3 wt %, and 5 wt %). The error bars in the
calibration curves in Figure 21 represented the standard deviation of spectrophotometer measurements
averaged for three cuvettes per dose level. The RA released iron(III) from its complex with xylenol
orange and reduced it back to iron(II). For all concentrations of RA, rFOX was linear with respect to
orthovoltage dose (Figure 21). The sensitivity of rFOX was reduced with increasing concentrations of
RA. All calibration curve slopes dropped most significantly in the first 24 hours and continued to drop
close to 0 (indicating the complete reversal of optical signal) up to 96 hours post-irradiation and was
dependent on RA concentration (faster reversal for higher concentrations of RA). From these results,
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an RA concentration of 9 wt % were used for larger volumetric rFOX dosimeters to ensure reversal of
signal by at least 24 hours.

Figure 21: a) Spectral response of rFOX immediately (as realistically possible) after irradiation with
peaks at 432 nm and 585 nm. Calibration curves at 432 nm b) immediately post-irradiation, d) 24
hours post-irradiation, f) 48 hours post-irradiation, h) 72 hours post-irradiation, and j) 96 hours
post-irradiation. Calibration curves at 585 nm c) immediately, e) 24 hours, g) 48 hours, i) 72 hours,
and k) 96 hours. The error bars in the calibration curves represented the standard deviation of
spectrophotometer measurements averaged for three cuvettes per dose level.
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3.2.2 Post-irradiation MR linearity
Post-irradiation MR linearity was only measured for rFOX up to approximately 20 Gy with R2
= 0.99 (Figure 22). The error bars represent the standard deviation from the regions of interest measured
within the irradiated region in each dosimeter. The raw MR signal intensities are shown in Figure 22
without subtraction of the 0 Gy sample (so intercept of linear fit is not close to 0). The standard
deviations of the raw MR signal intensities were on average ±4.8% of the mean raw MR signal intensity.

Figure 22: Post-irradiation MR linearity of rFOX. The error bars represent the standard deviation
from the regions of interest measured within the irradiated region in each dosimeter.

3.2.3 Real-time MR linearity
Real-time MR linearity was measured for FOX and rFOX in the same irradiation set-up and
bFFE sequence (TR/TE = 5/2.4 ms) with temporal resolution of 275 ms. The real-time MR signal
intensity was linear with respect to time and dose (constant dose rate delivered) for FOX in gelatin,
FOX in gelatin and agarose, and rFOX in gelatin and agarose (R2 = 0.82 to 0.87) (Figure 23). The
relative MR signal intensity was calculated for each dosimeter by dividing all MR signal intensities by
the un-irradiated MR signal intensity at the start of image acquisition. The error bars represent the
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propagated standard deviation from the regions of interest measured within the irradiated region and
outside the irradiated region in each dosimeter. Further results on the real-time MR linearity and bFFE
sequences will be discussed in Chapter 4.
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Figure 23: Real-time MR signal intensity linearity with dose for a) FOX in gelatin, b) FOX in gelatin
and agarose), and c) rFOX in gelatin and agarose. The error bars represent the propagated standard
deviation from the regions of interest measured within the irradiated region and outside the
irradiated region in each dosimeter.
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3.3 Radiological properties
The radiological properties and water equivalence of other 3D dosimeters have been presented
in the past [139–141]. The interaction probability, mass attenuation coefficient ratio, mass energy
absorption coefficient ratio, mass collision stopping power ratio, and mass radiative stopping power
ratio were calculated using the National Institute of Standards and Technology (NIST) XCOM (photon
cross sections database) and NIST ESTAR (stopping power and range tables for electrons) using the
elemental composition of FOX in comparison with water (Figure 24 and Figure 25). All radiological
properties demonstrated that FOX was nearly water-equivalent, with interaction probabilities nearly
overlapping that of water (Figure 24) and ratios within 3.5% of water (Figure 25)

Figure 24: Interaction properties for water and FOX.
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Figure 25: a) Mass attenuation coefficient ratio, b) mass energy absorption coefficient ratio, and
stopping power ratios (collisional, radiative, and total) for FOX and water.
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The mass attenuation coefficients, mass energy absorption coefficients, and stopping power
ratios for FOX were calculated by summing the individual values for each element and multiplying by
their fractional mass (elemental composition by weight fraction given in Figure 24). As mentioned
above, the elemental coefficients were calculated using the NIST XCOM database. The approximations
using these calculations were estimated to have a maximum error of 5% [141–144]. FOX has a higher
mass attenuation coefficient ratio and mass energy absorption coefficient ratio for energies less than
0.1 MeV due to iron’s photoelectric cross section (Figure 25). Above energies of 0.1 MeV, these ratios
closely approximate the relative electron density due to the higher interaction probability of Compton
scatter (or incoherent scatter, which depends on number of electrons) (Figure 24). Similarly, the
collisional stopping power ratios were approximately the electron density ratios (collisional stopping
power is proportional to electron density). On the other hand, the radiative stopping power ratios were
proportional to the atomic number(atomic number + 1). Overall, the radiological properties
demonstrated that FOX was nearly water-equivalent, with interaction probabilities nearly overlapping
that of water (Figure 24) and ratios within 3.5% of water (Figure 25)

3.4 Reproducibility
For reproducibility testing, intra-batch (within one batch) and inter-batch (between batch)
variability were tested. For intra-batch variability, the same dose of approximately 4 Gy was delivered
10 times from one batch in both without and with 1.5 T B0 field present using a Co-60 source. A linear
fit was applied for intra-batch comparison (a slope of 0 was expected for a zero intra-batch variability).
For inter-batch variability, the same doses up to approximately 8.2 Gy were delivered to 6 separate
batches. As expected, the inter-batch variability was greater than the intra-batch variability (Figure 26).
The linearity of the dose response was preserved across all batches. The error bars in the calibration
curves represented the standard deviation of spectrophotometer measurements averaged for three
cuvettes per dose level. The greatest intra-batch variability was 5% measured at 440 nm. The greatest
inter-batch variability was 10% measured at 440 nm for the calibration slope and 13% measured at 440

48
nm for a single dose point (2 Gy dose point). The greatest intra-batch variability was 4% measured at
585 nm. The greatest inter-batch variability was 7% measured at 585 nm for the calibration slope and
7% at 585 nm for a single dose point (8 Gy dose point).

Figure 26: Reproducibility testing for FOX. a) Intra-batch variability with 10 irradiations from one
batch of approximately 4 Gy (measured at spectral peak of 440 nm), b) intra-batch variability (585
nm), c) inter-batch variability from 6 batches (440 nm), and d) inter-batch variability (585 nm). The
error bars in the calibration curves represented the standard deviation of spectrophotometer
measurements averaged for three cuvettes per dose level.

3.5 Time stability
To ensure that repeat measurements for time stability studies were not affected from repeat
exposure to the xenon lamp in the spectrophotometer for the range of wavelengths relevant for the FO
gel formulation, which were also in the range of wavelengths used for the FOX gel (Figure 27). With
repeat exposure to a broad range of wavelengths in the spectrophotometer, conversions of iron ions
may occur (and appeared to be near-linearly related to the number of exposure, R2 = 0.99). The standard
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deviation of 30 consecutive spectrophotometer measurements was no more than ±0.5% of the mean
OD, compared to up to ±10% standard deviation from the mean MR signal.

Figure 27: The effect of repeat spectrophotometer xenon lamp exposures on consecutive optical readout of FO gel measured at 512 nm. The center dotted line represents the mean value from the 30
readings. The surrounding dotted lines show the bounds from the mean value considering the
standard deviation of the 30 readings. The increase in net OD with repeat exposure to the xenon lamp
was found to be linear (R2 = 0.987).

To investigate time stability post-irradiation, FOX was irradiated to approximately 4 Gy then
repeatedly measured for up to 68 days when stored at either room temperature or at 4 ºC with three
cuvette samples per environment (stored with covers to minimize the evaporation of water) (Figure 28).
The stability for 4 Gy, 0 Gy, and net 4 Gy (4 Gy – 0 Gy) was best preserved over 68 days when stored
at 4 ºC and measured at the spectral peak of 440 nm. The stability of FOX when stored at room
temperature plateaued after irradiation for up to 12 days then changed over the course of 56 days (Figure
28). Although both room temperature and 4 ºC samples were stored in boxes to prevent stray light
affecting the samples, it was possible that more stray light reached the room temperature FOX. Also,
gelatin lost its rigidity over time when stored at room temperature, which would also affect the OD
values (by affecting the amount of light absorbed, scattered, and transmitted). These results encourage
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the storage of FOX at 4 ºC. Although the OD values remained fairly stable at 4 ºC storage in cuvettes,
for volumetric studies, this would not be sufficient for preventing diffusion of the signal, eventually
distorting the dose distribution. Overall, the OD values were not expected to remain 100% stable for
any scenario of storage due to spontaneous chemical oxidation of iron(II) to iron(III) over time in the
presence of dissolved oxygen (the oxidation reaction could not occur in the presence of irradiation if
oxygen is purged, so this is an unavoidable consequence of Fricke-type gels) [145].

Figure 28: Time stability of FOX measured for 4 Gy (red triangles), 0 Gy (blue squares), and net 4
Gy (black diamonds) when stored at a) room temperature (measured at spectral peak 440 nm), b)
room temperature (585 nm), c) 4 ºC (440 nm), and d) 4 ºC (585 nm). The error bars in the curves
represented the standard deviation of spectrophotometer measurements averaged for three cuvettes
per time point and per dose level.

3.6 Energy dependence
The energy dependence of FOX was tested using a clinical Varian TrueBeamTM linac with 6
MV and 18 MV radiation beams, a clinical Elekta Versa HDTM linac with 6 MV and 10 MV radiation
beams, a 1.25 MeV Co-60 source (1.17 MeV and 1.33 MeV gamma rays), 250 kVp using an
orthovoltage unit, and a pre-clinical 7 MV Elekta MR-Linac. The percent differences in net OD relative
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to 7 MV (MR-Linac) were -1±2.5%, +1±2.5%, +2±6.5%, +5±6.5%, +4±6.5%, and -11±6.5% at 440
nm for 6 MV (Varian), 18 MV (Varian), 6 MV (Versa), 10 MV (Versa), 1.25 MeV (Co-60), and 250
kVp (Orthovoltage), respectively. The percent differences in net OD relative to 7 MV (MR-Linac) were
-2±2%, +2±2%, +6±3.5%, +9±3.5%, +8±3.5%, and -10±3.5% at 585 nm for 6 MV (Varian), 18 MV
(Varian), 6 MV (Versa), 10 MV (Versa), 1.25 MeV (Co-60), and 250 kVp (Orthovoltage), respectively.
Some differences between machines were due to intra-batch variability (up to 5% at 440 nm and 4% at
585 nm) and inter-batch variability (up to 13% at 440 nm and 7% at 585 nm across 6 batches for a
single dose level) (one batch was used for Varian and MR-Linac irradiations, and one batch was used
for Versa, Co-60, and orthovoltage irradiations). Uncertainties stated above were plus or minus half of
the maximum variability for intra-batch (Varian and MR-Linac values) and inter-batch (Versa, Co-60,
and orthovoltage values) irradiations.

Figure 29: Energy dependence of FOX relative to net OD measured for 7 MV (MR-Linac). The error
bars in the curves represented the standard deviation of spectrophotometer measurements averaged
for three cuvettes per irradiation.
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3.7 Reusability
The reproducibility of the reusable version of FOX, rFOX, was tested with repeat irradiations
of approximately 10 Gy separated by at least 24 hours between each irradiation (Figure 30). The relative
net MR signal intensity was calculated as the irradiated region’s signal intensity divided by the unirradiated region’s signal intensity for each repeat irradiation. The initial net MR signal intensity
response was lower when compared to following repeat irradiations due to irradiating the gel while still
cold, having recently removed it from 4° C storage. Temperature of the gel can affect the overall
sensitivity to irradiation as well as the weak magnetic interactions affecting temperature-dependent
magnetic moments [64, 146]. Fluctuations in the relative net signal intensity between repeat irradiations
may also be due to incomplete reversion of iron(III) to iron(II) inside the gel. Between all repeat
irradiations, rFOX was stored at room temperature away from bright lights. The real-time response of
rFOX remained linear throughout these repeat irradiations and will be discussed in further detail in
Chapter 4.

Figure 30: Reproducibility of net MR signal intensity response shown for rFOX irradiated with
approximately 10 Gy each time with at least 24 hours separating each repeat irradiation. The relative
net MR signal intensity was calculated as the irradiated region’s signal intensity divided by the unirradiated region’s signal intensity for each repeat irradiation. The error bars represent the
propagated standard deviation from the regions of interest measured within the irradiated region and
outside the irradiated region in each dosimeter.

53

3.8 Dose rate dependence
Dose rate dependence was tested for FOX and rFOX by changing the gun duty cycle from
100% down to 50% (Figure 31). Unlike the dose rate dependence tested in Figure 15 of FO using
different distances from the radiation source, this method of changing the gun duty cycle does not
change the instantaneous dose rate (amplitude of each pulse). The monitor unit (MU) rate at 100% gun
duty cycle was roughly 500 MU/min (~500 cGy/min at calibration depth). rFOX was imaged with MR
using two different sequences: T1 contrast enhancement (CE) and no CE. T1 CE and no CE are Philipsspecific terminology for their 3D fast field echo (FFE) sequences and do not indicate that an MR
contrast agent was injected. The T1 CE sequences spoiled the transverse magnetization using pulse
phase cycling of the radiofrequency excitation pulses. Therefore, the no CE images included a mixed
signal of the free induction decay (FID) and spin echo, and the T1 CE images only contained the FID
signal. As a result, no CE images contain more overall MR signal and reduced apparent noise (smaller
standard deviations). The relative values were calculated as the net value divided by the net value at
100% gun duty cycle. For FOX, the percent differences were -2±2.5% and -1±2.5% at 440 nm and 1±2% and -0.1±2% at 585 nm for 80% and 50% gun duty cycle, respectively. The uncertainties in the
percent differences for FOX were half of the maximum uncertainty in intra-batch measurements for
440 nm (5%) and 585 nm (4%), respectively. For rFOX, the percent differences were 1±4% and 1±5%
for no CE and 2±12% and 3±11% for T1 CE for 80% and 50% gun duty cycle, respectively.
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Figure 31: Dose rate dependence of a) FOX and b) rFOX. c) Example MR images of rFOX with no
CE and T1 CE acquisitions. MR images acquired with no CE were smoother with lower standard
deviation. The relative values were calculated as the net value divided by the net value at 100% gun
duty cycle. The error bars in a) represent the standard deviation of spectrophotometer measurements
averaged for three cuvettes per dose level and b) represent the propagated standard deviation from
the regions of interest measured within the irradiated region and outside the irradiated region in
each dosimeter.
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3.9 Fractionation dependence
FOX was tested for fractionation dependence up to a total of 12 Gy: 12 Gy delivered in one
fraction, 12 Gy delivered in 3 fractions of 4 Gy with no time gap between fractions, and 12 Gy delivered
in 3 fractions of 4 Gy with 20 minutes between fractions (Figure 32). rFOX was tested for fractionation
dependence up to a total of 20 Gy: 20 Gy in one fraction, two fractions (10 Gy each), four fractions (5
Gy each), five fractions (4 Gy each), and ten fractions (2 Gy each) with the same total time of delivery
for all fractionations (Figure 32). The terminology “fractionation” here does not refer to the
fractionation scheme of radiation treatment, typically separated by 24 hours. This fractionation was to
test the dependence on the delivery of multiple separate beams for a given radiation plan. For FOX, the
percent differences compared to 12 Gy x 1 were -0.4±2.5% and -2±2.5% at 440 nm and -2±2% and 0.3±2% at 585 nm for 4 Gy x 3 and 4 Gy x 3 (20 min), respectively. The uncertainties in the percent
differences for FOX were half of the maximum uncertainty in intra-batch measurements for 440 nm
(5%) and 585 nm (4%), respectively. For rFOX, the percent differences for the calibration curve slopes
(not plotted in Figure 32) compared to that of 20 Gy x 1 were -6±3%, -2±3%, -2±3%, and -8±3% for 2
Gy x 10, 4 Gy x 5, 5 Gy x 4, and 10 Gy x 2, respectively, with R2 = 0.99 to 1. Uncertainties for rFOX
were calculated from the standard deviation of all of the calibration curve slopes and for the calibration
curve slope including all values.
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Figure 32: Fractionation dependence of a) FOX and b) rFOX. The relative net OD values were
calculated as the net value divided by the net value at 12 Gy x 1. The error bars in a) represent the
standard deviation of spectrophotometer measurements averaged for three cuvettes per irradiation
and b) represent the standard deviation from the regions of interest measured within the irradiated
region in each dosimeter (raw MR signal intensity given here).
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3.10 Gel matrix dependence and diffusion
The FOX gel formulation was further modified in-house with the addition of a reducing agent
(9 wt %, water content reduced to ~87 wt %) to produce a reusable gel (rFOX). However, the reducing
agent in rFOX was also found to affect the rigidity of gelatin, so the gel matrix was changed to 3 wt %
gelatin and 1 wt % agarose. The FOX gel was created in both 4 wt % gelatin and 3 wt % gelatin and 1
wt % agarose to compare changes in radiation sensitivity with rFOX in 3 wt % gelatin and 1 wt %
agarose. All gels were contained in 4.5 cm diameter cylindrical PET plastic containers for irradiation
and MR imaging. FOX in gelatin and agarose, and rFOX in gelatin and agarose were assessed with
irradiation of approximately 10 Gy (Figure 33). The net percent signal intensity increases determined
from the post-irradiation T1-weighted images were 20.5±2%, 26.0±2%, and 21.4±2% for a) FOX in
gelatin (4 wt %), b) FOX in gelatin (3 wt %) and agarose (1 wt %), and c) rFOX in gelatin (3 wt %)
and agarose (1 wt %), respectively. Optically, the use of agarose instead of gelatin had previously been
shown to decrease the sensitivity of FXG [147]. The results of this study indicated that the incorporation
of agarose with gelatin slightly increased the radiation sensitivity of FOX measured using MRI.

Figure 33: Gel matrix dependence. Post-irradiation T1-weighted images (TR/TE = 500/20 ms) of a)
FOX in gelatin (4 wt %), b) FOX in gelatin (3 wt %) and agarose (1 wt %), and c) rFOX in gelatin (3
wt %) and agarose (1 wt %).
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Diffusion of FOX and rFOX (same samples imaged and shown in Figure 33) were measured
up to 28 days post-irradiation (Figure 34). As shown in Figure 34, the radiation beam edge regions were
approximately linear. The change in slopes over time are also listed in Table 9 as well as the percent
differences in slopes relative to the slope measured at 14 minutes post-irradiation for FOX and 0
minutes post-irradiation for rFOX in Table 10 since they were difficult to distinguish from Figure 34.
Overall, the slopes decrease over time. Notably for FOX in gelatin or gelatin and agarose, the overall
signal also gradually rose due to spontaneous oxidation of FOX at room temperature. On the other
hand, for rFOX, the overall signal gradually decreased as expected as the signal reverted. The change
in the irradiated region’s signal for rFOX was shown over time to demonstrate the speed of reversal of
signal (Figure 35). The first two hours of signal change for rFOX were found to be linear and are
recommended for volumetric relative dose measurements (Figure 35).
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Figure 34: Diffusion of signal for a) FOX in gelatin, b) FOX in gelatin and agarose, and c) rFOX in
gelatin and agarose for up to 28 days.
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Table 9: Slopes of radiation field edge over time for FOX and rFOX.
Time
0 min
14 min
20 min
26 min
30 min
40 min
50 min
1 hr
1 hr 20 min
1 hr 40 min
2 hr
4 hr 30 min
5 hr
24 hr
48 hr
5 days
28 days

FOX
(gelatin)
9.85
13.41
14.26
13.25
14.13
14.47
14.00
13.73
16.08
12.86
12.18
9.63
8.22
6.39
5.16
3.34
3.42

FOX
(gelatin and agarose)
6.28
10.64
10.51
10.44
11.77
11.87
11.97
10.77
10.38
9.90
10.73
5.67
5.60
4.44
4.22
1.99
2.79

rFOX
(gelatin and agarose)
6.08
6.25
7.38
5.04
4.64
4.80
5.30
6.01
5.15
4.18
1.81
1.57
1.70
-0.53
-0.05
-0.03
-0.55

Table 10: Percent differences in slopes of radiation field edge over time for FOX and rFOX relative
to slope measured at 14 min post-irradiation for FOX and 0 min post-irradiation for rFOX.
Time
0 min
14 min
20 min
26 min
30 min
40 min
50 min
1 hr
1 hr 20 min
1 hr 40 min
2 hr
4 hr 30 min
5 hr
24 hr
48 hr
5 days
28 days

FOX
(gelatin)
-26.5%
0.0%
6.3%
-1.2%
5.4%
7.9%
4.4%
2.4%
19.9%
-4.1%
-9.2%
-28.2%
-38.7%
-52.3%
-61.5%
-75.1%
-74.5%

FOX
(gelatin and agarose)
-41.0%
0.0%
-1.2%
-1.9%
10.6%
11.6%
12.5%
1.2%
-2.4%
-7.0%
0.8%
-46.7%
-47.4%
-58.3%
-60.3%
-81.3%
-73.8%

rFOX
(gelatin and agarose)
0.0%
2.8%
21.4%
-17.1%
-23.7%
-21.1%
-12.8%
-1.2%
-15.3%
-31.3%
-70.2%
-74.2%
-72.0%
-108.7%
-100.8%
-100.5%
-109.0%
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Figure 35: rFOX reversal of raw MR signal intensity. a) Change in signal up to 28 days and b)
zoomed in view to first 24 hours. The decrease in signal in the first two hours was found to be linear.
The error bars represent the standard deviation from the regions of interest measured within the
irradiated region at each time point.
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Other gel matrixes were tested for FOX but resulted in oxidation of iron(II) during the curing
process, did not cure, or resulted in no optical or MR visible changes after irradiation (Table 11). For
non-water based matrixes, a variety of solvents and surfactants were tested: chloroform, acetone, Triton
X-100, ethanol, and methanol. All tested gel matrixes were optically clear materials on their own.
Table 11: Gel matrixes tested for FOX formulation.
Name of matrix
Encapso® K
SS-5060
QSil 216
Sylgard® 184
Clear Flex 30
Crystal Clear 202
Crystal Clear 206
Epoxy Hydrogel
Sodium polyacrylate
Xanthan gum
Gellan gum (Phytagel)

Type of matrix
Encapsulation rubber
Silicone
Silicone
Silicone
Urethane rubber
Urethane resin
Urethane resin
Hydrogel
Super-absorbing polymer
Polysaccharide polymer
Polysaccharide polymer

Reason(s) for failure
Oxidation, did not cure
No change post-irradiation
Oxidation, did not cure
Did not cure
No change post-irradiation
No change post-irradiation
Oxidation
No change post-irradiation
No change post-irradiation
Did not gel firmly
Did not gel firmly

3.11 Summary
The dose linearity, radiological properties, reproducibility, time stability, energy dependence,
reusability of rFOX, dose rate dependence, fractionation dependence, gel matrix dependence, and
diffusion were investigated for FOX and rFOX. Both FOX and rFOX were found to be linear with
respect to radiation dose optically and with MR. Radiological properties of FOX demonstrated that it
was nearly water-equivalent. The intra-batch and inter-batch variabilities were quantified (up to 5%
intra-batch and up to 13% inter-batch) to demonstrate the reproducibility of FOX, which can be affected
by batch-to-batch differences in concentrations of chemicals due to scale and human uncertainties. The
time stability of FOX was most ideal when stored at 4 ºC. Up to 11±6.5% energy dependence, up to
3±11% dose rate dependence, and up to 8±3% fractionation dependence were found for FOX and rFOX
for energies and doses relevant for the MR-Linac. The reusability of rFOX was also demonstrated over
repeated irradiations of rFOX separated by at least 24 hours. The addition of agarose to FOX increased
it MR signal intensity change post-irradiation by 27% compared to gelatin alone. The change in MR
signal intensity for rFOX was -18% compared to FOX in gelatin and agarose (same gel matrix as
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rFOX). Within the first hour of measurement, changes in the slope at the radiation field edge due to
diffusion (as well as iron(III) reversal for rFOX) were less than 8% for FOX (gelatin), 13% for FOX
(gelatin and agarose), and 24% for rFOX (gelatin and agarose). One hour is within the timescale of
MR-Linac irradiations and immediate post-irradiation imaging. The decrease in MR signal intensity for
rFOX (correlating to the reversal of iron(III) to iron(II)) was linear within the first two hours (R 2 =
0.99). Indicating that the linear scaling of MR signal intensity from T1-weighted MR images to relative
dose can reliably be calculated for rFOX within the first two hours of measurement (disregarding
diffusion and only considering the fading of the MR signal intensity).

64

Chapter 4 – Magnetic field effects on volumetric dosimeters

4.1 Rationale
The perpendicular orientation of the strong magnetic field (B0) with respect to the radiation
beam in systems integrating an MRI with a linac or Co-60 unit influences secondary electrons resulting
in changes in dose deposition in three dimensions [56, 57]. However, conventional quality assurance
(QA) tools lack the ability to report changes in volumetric dose distributions and discrepancies out of
the plane of measurement [85, 148]. Conventional QA tools such as ionization chambers, film, and
other detectors also exhibit varying degrees of B0 field dependence [55, 57, 116, 149–155]. The effect
of B0 field on newer detectors, such as plastic scintillators, have also been recently investigated due to
the growing interest in applying such detectors for MR-IGRT applications [156–158]. To meet the need
for volumetric and potentially B0 field-independent dose evaluations, several 3D dosimeter types have
been applied to MR-IGRT systems to assess the electron return effect, B0 field effects on the radiation
field penumbra, and the feasibility of 3D dosimeters for assessing treatment planning system (TPS)
calculations and treatment plan deliveries [108, 114–116, 121, 124–126]. Prior to full volumetric dose
distribution analysis using 3D dosimeters, it was necessary to investigate whether the presence of a B0
field and gradient/radiofrequency fields present during MR imaging would require correction factors
to be applied for MR-IGRT applications. Other MR imaging considerations that could impact
calculated dose distributions were also discussed (these MR considerations are relevant to any MRI
system and not specific to the MR-Linac).

4.2 Strong magnetic field dependence
To reduce variability due to inter-batch and day-to-day differences, an electromagnet (GMW
Dipole Electromagnet Model #3472-70, GMW, San Carlos, CA, USA) was used for same-day
irradiations with and without a B0 field for all dosimeters (Figure 36). The B0 field strength inside the
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electromagnet was measured using a gaussmeter at the beginning and end of each set of irradiations
(Gaussmeter Model GM2, AlphaLab, Inc., Salt Lake City, UT, USA). A B0 field of 1.5 T with 50 mm
pole caps was used for FOX. FOX dosimeters were positioned consistently inside an acrylic phantom
(80 cm SSD at the surface of the phantom) and were irradiated with a 5 x 13 cm2 field using a Co-60
source. The distance between the pole caps with the acrylic phantom between the pole caps was
approximately 3 cm. The acrylic phantom served as a scatter medium providing 5 cm of build-up and
5 cm of backscatter material for the dosimeters. The cuvette insert dimensions inside the acrylic
phantom were 12.5 x 12.5 mm2, and the outer dimensions of the cuvettes were 12.5 x 12.5 mm2. This
resulted in no measurable air gap between the acrylic phantom and cuvette to prevent the presence of
electron return effects in the dosimeters. The Co-60 doses were calculated accounting for exponential
decay of the source and PDD using BJR Supplement 25 depending on the SSD, depth of measurement,
and field size [128].
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Figure 36: a) Schematic of electromagnet and location of phantoms when inserted between pole caps
with the directions of the B0 field and radiation beam noted; b) acrylic phantoms with cuvette inserts
used for FOX irradiations (sample cuvette in insert). Black dots in phantom and in sample cuvette
indicate region of optical measurement using a spectrophotometer in relation to the radiation field
(shaded region); and c) profile of 1.5 T B0 field strength in between pole faces (50 mm) of
electromagnet. The error bars represent the standard deviation from three readings of the B0 field
strength.

FOX dosimeters were measured at spectral peaks of 440 nm and 585 nm (Figure 37). The full
dose calibration curves and each dose level were compared. Percent differences in slope of 1.6±2.5%
and 0.5±2% were calculated for the full dose curves at 440 nm and 585 nm, respectively. The greatest
percent difference at a given dose level was 2.3±2.5% at 6 Gy at 440 nm (Figure 37). Because FOX
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and other iron-based radiochromic gels contain a ferromagnetic iron component, the B0 field effect was
evaluated for time dependence with FOX dosimeters at the 4 Gy dose point with five different lengths
of time in the 1.5 T B0 field (0, 6, 7, 10, and 30 minutes) (Figure 37). The percent differences for
measurements at the spectral peak 440 nm were 1.9±2.5%, 4.1±2.5%, 2.1±2.5%, and 3.3±2.5% for 6,
7, 10, and 30 minutes when compared to 0 minutes, respectively. Likewise at the spectral peak 585 nm,
the percent differences were 2.5±2%, -0.9±2%, 2.5±2%, and 0.2±2% for 6, 7, 10, and 30 minutes,
respectively. The data at neither spectral peak trended with respect to time of exposure to the 1.5 T B0
field, supporting no significant dependence on the B0 field.
FOX dosimeters consisted of ferromagnetic iron(II) oxide and polarized oxygen molecules
with intermediate radicals [63]. While the presence of B0 fields could potentially alter the response and
sensitivity of iron-based radiochromic gels, I found that this was not the case at 1.5 T with dosimeters
having been exposed to the B0 field for up to 30 minutes and for doses up to 8 Gy. FOX and other ironbased radiochromic gels may have B0 field dependence at greater than 1.5 T but this was not tested with
the electromagnet used for this study or the 1.5 T MR-Linac.
Although the geometry and beam quality were different, at depths beyond the build-up region
(5-25 cm), the difference in dose per incident photon with and without a 1.5 T B0 field was on the order
of 0.5% (lower dose with B0 field beyond build-up region) [55]. For FOX (440 nm), the calibration
curve slopes decreased in the presence of a B0 field. This agreed with the literature for findings with
PRESAGE® and with the 0.5% lower dose beyond the build-up region [116, 149, 150]. While
irradiating in a B0 field shifts the lateral edges of a radiation field, the measurements in this study were
well within the central region of the radiation field to minimize the contribution of penumbra changes
in a B0 field [117, 159, 160]. Unlike air-filled ionization chambers, the 3D dosimeters used in this study
filled their respective containers without the presence of air within the beam’s path. While small air
gaps between the acrylic phantom and silicone phantom and the 3D dosimeters could result in dose
enhancement due to the electron return effect, these effects were not within the scope of this study since
the radiation dose response measurements were averaged over an optical length of 1 cm for FOX [54,
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161]. Air cavities purposefully incorporated into PRESAGE® and FOX dosimeters have demonstrated
measurements of the electron return effect with good agreement with literature [116, 120]. Considering
the scale of dose differences beyond the build-up region and potential dose differences due to the
presence of small air gaps between the dosimeters and phantoms, the percent differences in response
with and without B0 fields were minimal for FOX [161].

Figure 37: a) net OD versus dose linear calibration curves without (R2 = 1.00) and with (R2 = 1.00)
1.5 T B0 field at spectral peak of 440 nm, b) linear calibration curves (R2 = 1.00) at spectral peak of
585 nm, and c) net OD for FOX dosimeters at 440 nm and 585 nm for varying lengths of time in the
1.5 T B0 field during irradiation to 4 Gy absorbed dose. The error bars represented the standard
deviation of spectrophotometer measurements averaged for three cuvettes per data point.
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B0 field dependence was repeated for FOX inside the MR-Linac with 0 T and 1.5 T
measurements separated by 9 days (1.5 T measurements were collected for the same batch of FOX used
for 0 T stored at 4 ºC in between irradiations and for a new batch of FOX prepared approximately 24
hours prior to 1.5 T irradiations) (Figure 38). Similar findings to the electromagnet irradiations were
found in the MR-Linac (Figure 38). At 440 nm, the calibration curve slopes were different from 0 T by
2±2.5% for the same batch at 1.5 T and 4±5% for the new batch at 1.5 T. The largest difference between
a single dose level was 7±6.5% at 2 Gy. At 585 nm, the calibration curve slopes were different from 0
T by 3±2% for the same batch at 1.5 T and 0±3.5% for the new batch at 1.5 T. The largest difference
between a single dose level was 8±3.5% at 2 Gy.
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Figure 38: a) net OD versus dose linear calibration curves without and with 1.5 T B0 field in MRLinac at spectral peak of 440 nm and b) linear calibration curves at spectral peak of 585 nm. The
error bars in the curves represented the standard deviation of spectrophotometer measurements
averaged for three cuvettes per data point.

4.3 Gradient and radiofrequency field dependence
For the gradient/radiofrequency (B1/RF) field dependence portion of the study, cuvettes were
placed inside a high impact polystyrene cuvette insert that was 1.3 cm thick. Water-equivalent plastic
backscatter material of 13.2 cm and build-up water-equivalent plastic of 6 cm were placed underneath
and above the cuvette insert plate, respectively. The cuvettes were irradiated with the same 10x10 cm2
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field and approximately 4 Gy for each B1/RF field scenario. The cuvettes were irradiated with 4
different real-time imaging sequences: (1) no imaging during irradiation, (2) TR/TE = 8/3.6 ms, B1 =
20 µT, maximum gradient mode, dB/dt = 20.5 T/s, (3) TR/TE = 8/3.6 ms, B1 = 20 µT, regular gradient
mode, dB/dt = 7.3 T/s, and (4) TR/TE = 8/3.6 ms, B1 = 3 µT, maximum gradient mode, dB/dt = 14.0
T/s (Figure 39). All real-time acquisitions had temporal resolutions of 400 ms. Relative to no real-time
MRI during irradiation (only B0 field present), the relative net OD was different by -1±2.5% for
scenario (2), -1±2.5% for (3), and -1±2.5% for (4) at 440 nm and by -1±2% for scenario (2), -1±2% for
(3), and -2±2% for (4) at 585 nm.

Figure 39: Assessment of potential B1/RF dependence on FOX gel using 4 different real-time bFFE
sequences at both 440 nm and 585 nm optical peaks: A) no real-time MRI during irradiation, B)
TR/TE = 8/3.6 ms, B1 = 20 µT, maximum gradient mode, dB/dt = 20.5 T/s, C) TR/TE = 8/3.6 ms, B1
= 20 µT, regular gradient mode, dB/dt = 7.3 T/s, and D) TR/TE = 8/3.6 ms, B1 = 3 µT, maximum
gradient mode, dB/dt = 14.0 T/s. Values for B, C, and D were normalized to A for both wavelengths.
All real-time acquisitions had temporal resolutions of 400 ms. The error bars represented the
standard deviation of spectrophotometer measurements averaged for three cuvettes per data point.

4.4 Other MR considerations
Real-time plots of MR signal intensity change previously shown demonstrated that after the
radiation beam was turned off, the signal continued to drift upwards, with lower slope. Since bFFE
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images produce more banding artifacts (or Gibbs ringing artifacts) than post-irradiation T1-weighted
images, the effect of the number of signal averages (NSA, also known as number of excitations NEX)
on the MR signal intensity was investigated (Figure 40). The temporal resolutions for NSA of 1, 2, 3,
and 4 were 231 ms, 476 ms, 710 ms, and 947 ms, respectively. NSA and its effect on banding artifact
on the real-time bFFE acquisition was assessed using only the rFOX gel with TR/TE = 3.8/1.92 ms for
all NSA. Gibbs ringing artifacts are deterministic and could be reduced but could never be completely
removed due to arising from the fundamental consequence of using Fourier transform to reconstruct
MR signals into images (Figure 47).
The standard deviation for the real-time relative MR signal intensity decreased with increasing
NSA (average standard deviation of 0.057, 0.033, 0.027, 0.024 for NSA = 1, 2, 3, and 4, respectively)
(Figure 40). However, the temporal resolution worsened with increasing NSA (the time for MR image
acquisition increases linearly with increasing NSA). The benefit of increasing NSA seemed to diminish
for NSA > 3. The linear fit was no longer improved for NSA = 4 and the signal within the irradiated
region began to decrease slightly during acquisition post-irradiation. The stability of the acquisition
pre-irradiation and post-irradiation was further investigated using NSA = 2 up to 10 minutes preirradiation and 20 minutes post-irradiation (Figure 41). While the MR signal intensity gradually drifts
downward prior to irradiation, the MR signal intensity remains relatively stable post-irradiation for up
to 20 minutes (Figure 41).
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Figure 40: Real-time relative MR signal intensity for a) NSA = 1, b) NSA = 2, c) NSA = 3, and d)
NSA = 4. The temporal resolution for NSA = 1, 2, 3, and 4 were 231 ms, 476 ms, 710 ms, and 947 ms,
respectively. The orange shaded regions indicate beam on times. The red lines indicate the relative
MR signal intensity in the irradiated region and the blue lines show the intensity in the un-irradiated
region. The error bars represent the propagated standard deviation from the regions of interest
measured within the irradiated region and outside the irradiated region in each dosimeter.
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Figure 41: Real-time relative MR signal intensity for NSA = 2 with temporal resolution of 476 ms
demonstrating stability of signal intensity pre-irradiation and post-irradiation for up to 10 minutes
and 20 minutes, respectively. The orange shaded region indicates beam-on time. The error bars
represent the propagated standard deviation from the regions of interest measured within the
irradiated region and outside the irradiated region in each dosimeter.

A 3D dose distribution was acquired by irradiating a FOX gel with two gantry angles (0° and
270°). The two beams were separated by approximately 24 seconds, including time for gantry rotation.
A central slice was imaged during irradiation to confirm the linear increase in MR signal intensity with
time (and dose with constant rate of approximately 540 ± 10 cGy/minute). The regions of interest within
and outside the beam path and change in MR signal intensity are also shown. Quantification of regions
of interest within the central slice demonstrate that the gel again responded linearly with time (and dose
with a constant dose rate) (R2 = 0.98 and 0.99). Volumetric snapshots for the FOX gel are shown below.
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Figure 42: FOX gel used for 3D dose acquisition in an 85 mm diameter and 60 mm tall PET
container. Post-irradiated T1-weighted images are shown to the right of the physical dosimeter
(irradiated and imaged in MR-Linac).

Figure 43: Real-time snapshot of FOX gel showing regions of interest used to assess un-irradiated
and irradiated regions. Images were acquired using a bFFE sequence of TR/TE = 4.4/2.2 ms with 12
slices per acquisition, NSA = 1, and temporal resolution of 1800 ms. The red line indicates the
relative MR signal intensity in the irradiated region and the blue line shows the signal in the unirradiated region. The error bars represent the propagated standard deviation from the regions of
interest measured within the irradiated region and outside the irradiated region.
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Figure 44: Real-time volumetric snapshots of FOX gel after irradiating to approximately a) 0 Gy, b)
5 Gy, c) 10 Gy, d) 15 Gy, e) 20 Gy, f) 25 Gy, and g) 30 Gy delivered to the center of the gel. The first
10 Gy were delivered with gantry angle 0° and the last 20 Gy with gantry angle 270°.

The volume dependence of FOX was investigated using 16 oz, 12 oz, and 4 oz PET containers
irradiated to the same doses. The percent increase in MR signal intensity post-irradiation was 26.7±3%,
27.4±2%, and 26.1±2% for 16 oz, 12 oz, and 4 oz FOX, respectively (Figure 45). These MR images
were acquired with TR/TE = 500/20 ms, turbo spin echo (TSE), and with reconstructed voxels of 0.35
x 0.35 x 3.00 mm3.
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Figure 45: a) MR images of FOX gels in 16 oz, 12 oz, and 4 oz containers pre-irradiation and postirradiation and b) MR signal intensities of those images. The error bars represent the standard
deviation from the regions of interest measured within the pre-irradiated and post-irradiated regions
in each dosimeter.

The MR images of FOX were also tested for gantry angle dependence since imaging could be
acquired at arbitrary gantry angle during and after plan delivery in Chapter 5. Gantry angles 0º, 90º,
180º, and 270º were investigated (Figure 46). These MR images were acquired with TR/TE = 11/4.6
ms, T1 CE 3D FFE, and with reconstructed voxels of 0.83 x 0.83 x 1.00 mm3. The percent MR signal
intensity increases were 42.3±3%, 43.1±3%, 42.8±3%, and 40.7±3% for gantry angles 0º, 90º, 180º,
and 270º, respectively.
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Figure 46: a) MR images of FOX gels for gantry angles 0º, 90º, 180º, and 270º pre-irradiation and
post-irradiation and b) MR signal intensities of those images. The error bars represent the standard
deviation from the regions of interest measured within the pre-irradiated and post-irradiated regions
in each dosimeter.

MR-sequence specific artifacts included fold-over artifacts, Gibbs ringing artifacts at
interfaces, zipper artifacts from PET plastic, and artifacts from super glue. These artifacts would arise
regardless of the MRI system and were not specific to the MR-Linac. Examples of such artifacts are
shown below in Figure 47. The presence of such artifacts could result in mis-analysis of dose when
converting the MR images to relative doses. Fold-over artifacts could be mitigated by increasing the
fold over suppression oversampling or by increasing the field of view acquired. Gibbs ringing artifacts
could be reduced in the gel on the right of Figure 47b but could never be completely removed due to
arising from the fundamental consequence of using Fourier transform of a truncated sync function to
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reconstruct MR signals into images. Zipper artifacts that generally occur with radiofrequency
contamination from electronic devices occurred with spin echo sequences in PET plastic (with gel or
water) but could be removed with a turbo spin echo sequence. The presence of super glue resulted in
an MR signal void (whether the jar was filled with gel or water) but was not true with the use of hot
glue. The main component of super glue is ethyl cyanoacrylate or another cyanoacrylate ester, which
consists of carbon, hydrogen, nitrogen, and oxygen. The MR signal void was most likely due to a
proprietary metal component that was not indicated in any technical data sheets.
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Figure 47: Examples of MRI artifacts. a) Fold over artifacts that could be remedied with suppression
oversampling or increased field of view, b) Gibbs ringing artifact that could be reduced in the gel on
the right but could never be completely removed due to arising from the fundamental consequence of
using Fourier transform to reconstruct MR signals into images, c) zipper artifact that generally
occurs with radiofrequency contamination from electronic devices occurred with spin echo sequences
in PET plastic (with gel or water) and remedied on the right with a turbo spin echo sequence, and d)
MR artifact due to super glue on bottom of jar (regardless of gel or water) but not present when hot
glue was used. Central black region was due to brass ball bearing.
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4.5 Summary
This chapter investigated MR-related considerations for volumetric dosimetry using MR
images including B0 field dependence, B1/RF field dependence, and potentials for MRI artifacts.
Overall FOX was found to have up to 4±5% B0 field dependence and up to 2±2% B1/RF field
dependence. The real-time MR signal intensity change with radiation dose remained linear for FOX
and rFOX regardless of the real-time bFFE sequence used. Example MRI artifacts that could affect the
conversion of MR signal intensities scaled to relative volumetric dose distributions were also discussed
for fold-over artifacts, Gibbs ringing artifacts at interfaces, zipper artifacts from PET plastic, and
artifacts from super glue.
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Chapter 5 – Volumetric phantom study

5.1 Rationale
MR-IGRT systems require a modified clinical workflow to integrate MR images for daily
adaptive re-planning. Conventional treatment plan delivery checks are conducted using quasi-3D arrays
such as the ArcCHECK or with 2D arrays. These are valuable clinical tools for quality assurance since
they are not time consuming to set-up and take measurements from (compared to having to process and
scan film for planar measurements). Dosimetry panels such as the IC Profiler (Sun Nuclear) and
Starcheck (PTW) allow for measurements in two perpendicular profiles and two diagonal profiles. The
detectors for these devices are distributed evenly over a surface. Investigations on the use of such
devices in a B0 field have been done [151, 153, 162]. The IC Profiler consists of 251 parallel plate
ionization chambers (0.05 cm3 sensitive volume per chamber) in its panel, with intrinsic build-up of 0.9
g/cm2 and backscatter of 2.3 g/cm2. A 1.5 T B0 field was found to affect the IC Profiler’s profile
measurements, but normalization profiles were comparable with that of film [151, 153]. The Starcheck
consists of 527 vented ionization chambers, again in two perpendicular profiles and two diagonal
profiles. The reference detector at the center position of the Starcheck was not always in the same
orientation of nearby detectors, depending on the profile measured, resulting in a discontinuity in the
profile [151, 153]. Similar to the IC Profiler, care must be taken when normalizing the Starcheck
ionization chamber measurement values. Quasi-3D arrays such as the ArcCHECK (Sun Nuclear) and
Delta-4 (Scandidos) have also been investigated in a B0 field [151, 153, 163, 164]. The ArcCHECK is
a cylindrical water-equivalent phantom consisting of an array of diodes near its perimeter with a 15 cm
wide center cavity (with an assortment of available plugs, including a plug for ionization chamber
reference dosimetry). The performance of the ArcCHECK in the 1.5 T MR-Linac was found to be
within 1% of its performance in a conventional linac [151, 153]. The Delta-4 is not yet commercially
available as an MR-compatible device. However, these devices cannot be MR imaged nor would they

83
provide valuable MRI information. Ideally, a fully anthropomorphic MR-visible and radiation-sensitive
phantom would be used for a complete end-to-end clinical workflow assessment. While commissioning
phantoms including CT and MR-visible materials are currently in development, these depend on point
and planar measurements using thermoluminescent dosimeters (TLDs) and film, which can miss dose
information in three dimensions [165, 166]. Compared to 3D gels, the implementation of a phantom
for multi-institutional and remote dosimetry is of course simplified with a commissioning phantom
with TLD and film inserts, with the understanding that volumetric dose distributions cannot be
quantified. Conventional plan verification anthropomorphic phantoms only included planar film and
point dosimeters (such as TLDs or ion chambers) and generally produced at best poor MR image
quality. For example, MR imaging of an anthropomorphic Rando phantom required placing an MRbright substance on top of the phantom and MR-visible PinPoint® #128 markers (Beekley Corporation,
Bristol, CT) to assist with fusion of the MRI with CT (Figure 48).

Figure 48: a) and b) The anthropomorphic Rando phantom imaged in the 1.5 T MR-Linac using the
following parameters: 300 slices with FOV of 400 x 400 x 300 mm3, reconstructed voxel 0.83 x 0.83 x
1 mm3, T1-weighted TR/TE = 11/4.6 ms, 3D FFE, and 30° flip angle. c) and d) CT of same phantom.
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To fill the need for a large volumetric, MR-visible, and radiation-sensitive phantom for endto-end assessment of MR-IGRT workflow, I utilized my rFOX and conventional FXG gel formulations
in both heterogeneous and homogeneous phantom studies.

5.2 Heterogeneous rFOX phantom results and discussion
The first investigation of end-to-end testing on the MR-Linac using a volumetric phantom was
done with a modified IROC-Houston head and neck phantom, commonly used for IMRT plan delivery
validation, with an rFOX insert (Figure 49). The rFOX gel insert was created with four different
heterogeneous components and one uniform homogeneous gel insert. The four heterogeneous
components were a 1.3 cm diameter solution, a 1.3 cm diameter gel, a 1.3 cm diameter air, and a 3 cm
diameter air (examples of 1.3 cm diameter and 3.0 cm diameter components shown in Figure 49). These
heterogeneous components were selected to mimic anatomical heterogeneities present in the human
body that can produce dose perturbations in a strong magnetic field. Relevant examples include tissues
similar to what was generalized as soft-tissue such as various soft organs and blood vessels (rationale
for including solution heterogeneity). Other examples include air cavities such as the sinuses and
trachea (rationale for including air heterogeneities of different sizes). The remainder of the head and
neck phantom was composed of plastic filled with water.
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Figure 49: Pictures of head and neck phantom and rFOX inserts. a) rFOX inside of phantom, b)
rFOX outside of phantom, c) example of 1.3 cm diameter heterogeneous component in rFOX, and d)
example of 3.0 cm diameter heterogeneous component in rFOX (purple regions were irradiated
areas).
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All of the combinations of rFOX inserts inside the head and neck phantom were initially CT
scanned with 120 kV, 250 mAs/slice, and 1 mm slice thickness. The CT number to electron density
(used for dose calculations in treatment planning systems) for 120 kV and the Philips Brilliance Big
Bore CT scanner are plotted below (Figure 50). The average CT numbers of the rFOX gels, water in
the phantom, and air were 20.3 ± 9.2, 3.2 ± 7.9, and -1002.6 ± 3.9, respectively. These CT numbers
could then be used to calculate the linear attenuation coefficient of each material, which was energy
dependent. The x-ray mass attenuation coefficient of water provided by NIST (µ/ρ) and the density of
water 1 g/cm3 were used to calculate the linear attenuation coefficients of rFOX and air using the
equation: µmaterial = (CT number x µwater / 1000) + µwater, where µwater = 0.142 cm-1 for 120 kV. µrFOX and
µair were calculated to be 0.145 cm-1 and 0.00036 cm-1, respectively, under these conditions. The
electron densities for all materials were calculated within Monaco TPS.

Figure 50: CT number to electron density conversion.

Reference plans were made in the Monaco TPS (research version 5.19.02) using the CT images
acquired of the rFOX inserts in the head and neck phantom. Complete cross-validation of the Monaco
TPS in a B0 field environment had not yet been done at the time of this dissertation work, so some
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uncertainties in dose are expected as a result (conventional TPS calculations include up to 3% dose
uncertainties in clinical use due to many different factors, including conversions of CT numbers to
electron density for dose calculations). Monaco TPS used Monte Carlo dose calculations in a graphical
processing unit environment that incorporated a 1.5 T B0 field. Daily T2-weighted, T1-weighted T1
CE, and T1-weighted no CE MR images were acquired for fusion with the CT to create the daily
adapted plan based on the phantom position in the MR-Linac. These daily adapted plans were then
delivered in the MR-Linac and post-irradiation MR images were acquired of the gels in the same
position. Prior to MR-IGRT systems, it was not possible to pre-scan, irradiate, and post-scan 3D
dosimeters all in the same position. With the MR-Linac and other MR-IGRT systems, we now have the
ability for delivering a treatment plan to a 3D dosimeter in the exact position that it was planned for
with the possibility for real-time onboard MR imaging during irradiation and immediate MR imaging
post-irradiation. The overall MR-IGRT workflow is shown below (Figure 51).
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Figure 51: Overall MR-Linac workflow. First, make a reference TPS plan from the CT. Next, fuse the
daily MRI with the CT and make an adapted plan. Next, deliver this plan and obtain a postirradiation MRI. Finally, compare the relative delivered dose with the planned dose.

Small differences (<0.3 mm) in fusion coordinates were found depending on the MR image
sequence used (T2-weighted, T1-weighted T1 CE, and T1-weighted no CE) (Table 12). Overall, T2weighted MR images were not recommended for fusion with CT due to greater distortions at interfaces,
distorting the geometric accuracies of sharp edges in the images (Figure 52). No differences in fusion
coordinates were found for MR images acquired at different gantry angles (Table 12), which agreed
with previous results of investigating MR signal intensities at different gantry angles (Figure 46). MR
images acquired with T1-weighted no CE were used for all fusion for adapted plans due to its superior
visibility of edges and reduced noise compared to T2-weighted and T1-weighted T1 CE (Figure 52).
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Table 12: Fusion translation coordinates for MRI with CT.
MRI sequence type
T2-weighted
T1-weighted T1 CE
T1-weighted no CE
T1-weighted no CE
T1-weighted no CE
T1-weighted no CE

Gantry angle
0º
0º
0º
90º
180º
270º

x (cm)
-0.0595
-0.0595
-0.0695
-0.0695
-0.0695
-0.0695

y (cm)
-49.2979
-49.2979
-49.2879
-49.2879
-49.2879
-49.2879

z (cm)
-8.1302
-8.1591
-8.1591
-8.1591
-8.1591
-8.1591

Figure 52: a) T2-weighted MRI, b) T1-weighted T1CE MRI, and c) T1-weighted no CE MRI.

Regardless of the NSA used for a given MRI acquisition, T2-weighted sequences used 3D TSE,
TR/TE = 1535/278 ms, field of view of 400 x 400 x 300 mm3, and reconstructed voxels of 0.83 x 0.83
x 1.00 mm3. T2-weighted acquisitions took 1:57 minutes with NSA = 1. T1-weighted T1 CE and T1weighted no CE sequences used 3D FFE and TR/TE = 11/4.6 ms with the same field of view and
reconstructed voxels dimensions as T2-weighted sequences. Both T1 CE and no CE acquisitions took
1:54 minutes, 5:42 minutes, and 9:29 minutes for NSA = 1, 3, and 5, respectively.
Due to some initial bugs in Monaco TPS that were addressed after this portion of the study,
rectangular 3D fields of 4 x 2 cm2 were delivered to the phantom; consequently, the adapted plans did
not perfectly match the irradiation conditions used so lower agreement between the rFOX calculated
relative dose and the Monaco TPS calculated dose were expected. 3D fields of 4 x 2 cm2 were delivered
as 1 beam (gantry angle 0º), 2 beams (0º and 180º), 3 beams (60º, 180º, and 300º), 4 beams (0º, 90º,
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180º, and 270º), and 7 beams (306º, 255º, 204º, 0º, 51º, 102º, and 153º). After acquisition of the preirradiation and post-irradiation MR images, the relative volumetric dose distributions quantified in the
gels were compared to Monaco TPS’s calculated doses using 3D Slicer (version 4.6.2) [167, 168]. 3D
Slicer was an open source software platform that could be used for a wide variety of applications and
has been validated for TPS plan comparisons using gamma analysis [116, 169]. The 3D Slicer workflow
is described below.
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Step 1: Install 3D Slicer software from http://download.slicer.org/ (the latest version available at the
time of this dissertation work was 4.6.2).
Step 2: Install the “SlicerRT” extension.
Step 3: Import dicom files (planned dose, structures, prescan, postscan, and etc.) using the “DICOM
Browser”. I preferred to use “Add link” rather than “Copy” due to the size of my files.
Step 4: Load the imported dicom files. If the prescan and postscan were acquired in the same study set,
load each series separately. If they are loaded at the same time from the same study set, then the values
will not appear as single scalar values for each, which means the prescan values cannot be subtracted
from the postscan values. After each piece is loaded, the screen will clear. Click on the “DCM” transfer
button to load the next series.
Step 5: Double check that everything was loaded by going to “Subject Hierarchy” (Figure 53).

Figure 53: “Subject Hierarchy” in 3D Slicer.
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Step 6: Go to “Subtract Scalar Volumes”. Select your postscan for “Input Volume 1” and prescan for
“Input Volume 2”, enter new output volume name, and click “Apply”. Wait until “Status: Completed”
(Figure 54).

Figure 54: “Subtract Scalar Volumes” in 3D Slicer.
Step 7: Go to “Transforms” to align your MRI volumes with your plan volumes (based on CT
coordinates). Depending on the coordinate systems of your MRI, CT and TPS, you may need to press
“Identity” or the image planes may be mismatched (for example, the sagittal plane will appear in the
axial plane and rotated incorrectly). You can then manually adjust the translation for LR, PA, and IS.
If using the MR-Linac system for acquiring your MR images and Monaco TPS, you may enter your
MR-Linac isocenter coordinates from Monaco TPS adapted plan (fusion translation coordinates already
applied from the daily MR images) as the following into 3D Slicer: X (cm)  –LR (mm) (may or may
not be +/–LR depending on how the MR images were exported, can be easily checked using the axial
plane view), Z (cm)  PA (mm), and Y (cm)  IS (mm). After you are satisfied with the transform
coordinates, go to “Convert”, select a reference volume (any of the MRI volumes), enter a name for the
“Output Displacement Field”, and press “Apply” (Figure 55).
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Figure 55: “Transforms” in 3D Slicer.
Step 8: Go to “Simple Filters”. Here you can select any post-processing image filters for denoising
(such as “MedianImageFilter” and others). Make sure to create a new “Output Volume” name to not
over-write your currently existing volumes. After creating any new volumes, you will need to go back
to “Transforms” and push those volumes over to the right side to be transformed. You will also do your
image scaling to a relative dose here using “ShiftScaleImageFilter”. “Shift” should be used for
background values first and then “Scale” for the relative dose inside irradiated regions. Make sure to
reset “Shift” to 0 and “Scale” to 1 after making any changes (and again, you may choose to over-write
a volume or create a new volume each time and then transform the new volume). In order to know what
values to enter, you may visualize the planned dose and your gel image as an overlay and see the values
of each pixel under “Data Probe” (Figure 56).
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Figure 56: “Simple Filters” in 3D Slicer.
Step 9: Once you have shifted and scaled your desired relative dose volume, go back to “Subject
Hierarchy” and make sure that this volume is under a study (notepad icon to left of study). If it is not,
then drag the series under a study (any study). Then right click on the gel series and select “Convert to
RT dose volume”. The icon to the left of the series should change from a gray cube to a multi-colored
cube (Figure 57).
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Figure 57: “Subject Hierarchy” to convert to RT dose volume in 3D Slicer.

Step 10: Once you have converted your desired relative dose volumes into RT dose volumes, go to
“Radiotherapy” then “Dose Comparison”. You may then enter in your 3D gamma criteria and dose
thresholds. You can select a “Mask structure” to only analyze dose within the gel and not for the entire
patient structure set. Again, enter in a new volume name for “Gamma volume” to not over-write any
existing volumes. Once you press “Calculate gamma”, you have your gamma analysis results (Figure
58)!
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Figure 58: “Dose Comparison” in 3D Slicer.

Step 11: Helpful shortcuts for manipulating your images are available here:
https://www.slicer.org/wiki/Documentation/4.4/SlicerApplication/MouseandKeyboardShortcuts.

Gamma analysis was used for comparison of the two dose distributions in this dissertation work
(relative dose calculated from MR images of gel and dose calculated from Monaco TPS). Gamma
analysis was developed by Low et al. to combine comparisons of dose and spatial information [170].
The minimum distance from a reference point from the reference dose (calculated from TPS) to the
measured point of the comparison dose (relative dose calculated from 3D dosimeter) is the gamma
index. A gamma index greater than 1 indicated a failing value. A gamma criteria of 7%/4mm distance
to agreement (DTA) was used by IROC for IMRT head and neck plans for 2D gamma analysis of film
[171]. While 3D dosimetry studies have used other gamma criteria for 3D gamma analysis (which
added another spatial dimension to 2D gamma analysis), 7%/4mm was used along with stricter gamma
constraints (5%/3mm and 3%/3mm) as a comparison with passing cutoffs of 80% [170–173]. While
85% is the typical passing cutoff, up to 5% differences in gamma pass rates were found depending on
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small changes to scaling for relative doses. As mentioned earlier, lower than normal gamma passing
rates (and therefore lower agreement between the two dose distributions) were expected for this portion
of the study due to initial bugs in Monaco TPS not allowing for the full MR-Linac workflow. A 10%
dose threshold was applied for all of the gamma analysis, regardless of the gamma criteria. Because of
the standard deviation due to the noise in the MR images (up to ~10% of the mean MR signal intensity),
it is important to note that there is a risk of voxels passing with 3D gamma analysis using loose criteria
(such as 7%/4mm used in this dissertation work). However, since the purpose of this development
project was to demonstrate the proof of concept of the end-to-end testing workflow using a 3D
dosimeter and to demonstrate the feasibility of doing so with heterogeneous and homogeneous 3D
dosimeters, both loose and tighter gamma criteria were used to analysis the relative volumetric dose
distributions.
As mentioned in the 3D Slicer Workflow, several image post-processing tools are built into the
software, including noise reduction filters, such as the MedianImageFilter and MeanImageFilter. The
MedianImageFilter (Figure 59) and MeanImageFilter (Figure 60) computed values of each output pixel
as a statistical median/mean of neighborhood values around a corresponding input pixel. The radius of
neighborhood pixel values to search can be specified in all three dimensions. While increasing the
radius of neighborhood pixel values to search improves the smoothness of the image, this could remove
thin structures and cause blurring of signal, such as in areas with steep dose gradients. Since noise in
the images were more prevalent in T1-weighted T1 CE images, an analysis of the ideal radius (same
radius value applied in all three dimensions) to use to post-process T1 CE images with NSA = 1 was
investigated for only the heterogeneous rFOX phantom with 1.3 cm solution insert for 1 beam delivery.
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Figure 59: a) Planned dose overlaid on CT image, b) calculated relative dose from rFOX (T1 CE,
NSA = 1) with no post-processing filter, c) MedianImageFilter radius 1, d) MedianImageFilter
radius 2, e) MedianImageFilter radius 3, f) MedianImageFilter radius 4, and g) MedianImageFilter
radius 5. The central region of rFOX that appears like a hot spot is due to the heterogeneous
component and was not used for dose comparisons since that region cannot be scaled appropriately.

Figure 60: a) Planned dose overlaid on CT image, b) calculated relative dose from rFOX (T1 CE,
NSA = 1) with no post-processing filter, c) MeanImageFilter radius 1, d) MeanImageFilter radius 2,
e) MeanImageFilter radius 3, f) MeanImageFilter radius 4, and g) MeanImageFilter radius 5. The
central region of rFOX that appears like a hot spot is due to the heterogeneous component and was
not used for dose comparisons since that region cannot be scaled appropriately.

Table 13: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm solution insert with
image post-processing. Pass rates above the 80% cutoff are highlighted in green.
Post-processing
No filter
MedianImageFilter
MedianImageFilter
MedianImageFilter
MedianImageFilter
MedianImageFilter
MeanImageFilter
MeanImageFilter
MeanImageFilter
MeanImageFilter
MeanImageFilter

Radius (pixel)
-1
2
3
4
5
1
2
3
4
5

7%/4mm
99.39%
98.30%
93.28%
85.09%
84.78%
82.37%
97.94%
91.16%
85.71%
82.67%
82.04%

5%/3mm
86.38%
87.85%
78.375%
66.30%
70.07%
69.84%
87.72%
77.04%
70.54%
65.38%
64.68%

3%/3mm
69.59%
74.95%
67.81%
56.62%
59.63%
58.27%
75.30%
65.89%
60.76%
54.69%
52.38%

Analysis of post-processing with both the MedianImageFilter (Figure 59) and
MeanImageFilter (Figure 60) for T1-weighted T1 CE NSA = 1 images showed that the pass rate was
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similar for no filter and with filters of radius 1 (Table 13). This indicated that careful shifting and scaling
of the original postscan – prescan images could be used for gamma analysis without any postprocessing. However, the addition of a filter with radius 1 did improve more strict gamma criteria pass
rates, so the MedianImageFilter with radius 1 was applied for all following T1 CE NSA = 1 images.
Overall, no CE gamma pass rates were higher than those for T1 CE for tighter gamma criteria even if
the looser 7%/4mm gamma pass rates were lower by less than 1.5% (could potentially be improved
with better scaling of relative dose). This indicated that the no CE images resulted in more informative
relative dose pixels spatially compared to T1 CE, which were noisier. no CE was also more accurate
with subtracting the prescan from the postscan as can be seen where the heterogeneous region appeared
black from being completely subtracted (Figure 61d). The 3D gamma pass rates and representative
images for the rFOX gel are below for 1.3 cm diameter solution heterogeneity (Table 14 and Figure
61), a 1.3 cm diameter gel heterogeneity (Table 15 and Figure 62), a 1.3 cm diameter air heterogeneity
(Table 16 and Figure 63), a 3 cm diameter air heterogeneity (Table 17 and Figure 64), and a uniform
gel (Table 18 and Figure 65). Representative images were shown with 1 beam irradiation for the 1.3
cm diameter solution insert (Figure 61), 2 beams irradiation for the 1.3 cm diameter gel insert (Figure
62), 3 beams irradiation for the 1.3 cm diameter air insert (Figure 63), 4 beams irradiation for the 3 cm
diameter air insert (Figure 64), and 7 beams irradiation for the uniform gel. All gels, regardless of the
heterogeneous insert, were irradiated with 1 beam, 2 beams, 3 beams, 4 beams, and 7 beams, separated
by at least 24 hours for the rFOX gel to revert to background levels. Before and after irradiation, all
rFOX gels were MR imaged with T1-weighted T1 CE and no CE sequences. For all images, the raw
pre-irradiated images were subtracted from the raw post-irradiated images. This was due to higher MR
signal intensities closer to the body and anterior coils in the MRI bore (as expected for any MRI system).
The purpose of subtracting the pre-irradiated images from the post-irradiated images was to mitigate
the influence of these signal non-uniformities in the MR images. After this subtraction, the T1-weighted
MR images were then scaled to the Monaco planned doses to obtain a relative volumetric dose
distribution. For future work, absolute volumetric dose distributions could be calculated from T1-
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weighted MR images or from quantitative T1-mapped MR images from planar and point dosimetry
values using calibrated film and ionization chamber values.

Table 14: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm solution insert. Pass
rates above the 80% cutoff are highlighted in green.
MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
no CE
no CE
no CE
no CE
no CE

NSA
1
1
1
1
1
1
1
1
1
1

# Beams
1
2
3
4
7
1
2
3
4
7

7%/4mm
99.39%
98.09%
97.92%
97.52%
98.30%
97.97%
97.48%
98.06%
97.52%
97.41%

5%/3mm
86.38%
79.28%
79.85%
80.56%
79.39%
87.68%
84.42%
80.84%
87.39%
77.63%

3%/3mm
69.59%
61.63%
63.10%
64.33%
61.63%
76.63%
69.39%
62.95%
74.13%
59.91%
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Figure 61: a) CT of rFOX with 1.3 cm solution insert, b) T2-weighted image, c) T1-weighted T1 CE
image, d) T1-weighted no CE image, e) Monaco TPS dose overlaid on CT, f) T2-weighted relative
dose (non-linear dose so not analyzed with gamma criteria), g) T1 CE relative dose, h) no CE
relative dose, i) gamma map of T2-weighted dose, j) gamma map of T1 CE dose, and k) gamma map
of no CE dose.
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Table 15: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm gel insert. Pass rates
above the 80% cutoff are highlighted in green.
MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
no CE
no CE
no CE
no CE
no CE

NSA
1
1
1
1
1
1
1
1
1
1

# Beams
1
2
3
4
7
1
2
3
4
7

7%/4mm
98.15%
96.02%
89.98%
87.71%
94.16%
97.01%
96.03%
92.74%
97.61%
98.38%

5%/3mm
85.24%
74.40%
63.57%
57.35%
81.58%
86.19%
83.20%
78.23%
85.16%
85.70%

3%/3mm
70.72%
56.87%
47.08%
41.35%
68.69%
75.51%
68.41%
51.06%
69.82%
69.74%
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Figure 62: a) CT of rFOX with 1.3 cm gel insert, b) T1-weighted T1 CE image, c) T1-weighted no CE
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g)
gamma map of T1 CE dose, and h) gamma map of no CE dose.
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Table 16: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm air insert. Pass rates
above the 80% cutoff are highlighted in green.
MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
no CE
no CE
no CE
no CE
no CE

NSA
1
1
1
1
1
1
1
1
1
1

# Beams
1
2
3
4
7
1
2
3
4
7

7%/4mm
98.57%
97.40%
95.15%
95.62%
92.34%
96.64%
96.92%
99.14%
98.07%
98.77%

5%/3mm
86.77%
78.14%
82.13%
76.74%
71.24%
86.12%
84.06%
86.12%
84.97%
86.58%

3%/3mm
72.43%
60.53%
68.79%
60.71%
55.52%
75.30%
69.62%
70.11%
69.66%
70.86%
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Figure 63: a) CT of rFOX with 1.3 cm air insert, b) T1-weighted T1 CE image, c) T1-weighted no CE
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g)
gamma map of T1 CE dose, and h) gamma map of no CE dose.
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Table 17: 3D gamma pass rates for heterogeneous rFOX phantom with 3.0 cm air insert. Pass rates
above the 80% cutoff are highlighted in green.
MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
no CE
no CE
no CE
no CE
no CE

NSA
1
1
1
1
1
1
1
1
1
1

# Beams
1
2
3
4
7
1
2
3
4
7

7%/4mm
95.39%
95.55%
92.49%
95.04%
91.61%
94.89%
95.40%
99.13%
98.27%
97.62%

5%/3mm
77.74%
71.90%
71.86%
75.62%
70.09%
84.30%
82.46%
87.64%
84.55%
83.56%

3%/3mm
61.89%
54.13%
58.06%
60.04%
54.51%
74.91%
67.78%
72.43%
68.43%
67.20%
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Figure 64: a) CT of rFOX with 3.0 cm air insert, b) T1-weighted T1 CE image, c) T1-weighted no CE
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g)
gamma map of T1 CE dose, and h) gamma map of no CE dose.
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Table 18: 3D gamma pass rates for homogeneous rFOX phantom. Pass rates above the 80% cutoff
are highlighted in green.
MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
no CE
no CE
no CE
no CE
no CE

NSA
1
1
1
1
1
1
1
1
1
1

# Beams
1
2
3
4
7
1
2
3
4
7

7%/4mm
97.61%
96.75%
94.83%
95.07%
93.24%
95.20%
96.50%
98.17%
97.98%
97.70%

5%/3mm
83.97%
75.02%
76.94%
77.02%
75.51%
84.56%
82.81%
83.03%
84.32%
84.73%

3%/3mm
69.21%
57.31%
62.18%
61.70%
61.13%
74.11%
67.96%
66.43%
68.73%
68.90%
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Figure 65: a) CT of uniform rFOX with no heterogeneous insert, b) T1-weighted T1 CE image, c) T1weighted no CE image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE
relative dose, g) gamma map of T1 CE dose, and h) gamma map of no CE dose.
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As mentioned earlier in Chapter 3, the T1 CE sequences spoiled the transverse magnetization
using pulse phase cycling of the radiofrequency excitation pulses. Therefore, the no CE images included
a mixed signal of the free induction decay (FID) and spin echo, and the T1 CE images only contained
the FID signal. As a result, no CE images contain more overall MR signal and reduced apparent noise
(smaller standard deviations). This was evident in the heterogeneous gel results because T1 CEcalculated relative dose comparisons failed more with tighter gamma criteria (5%/3mm and 3%/3mm)
compared to no CE 3D gamma pass rates (Table 14, Table 15, Table 16, Table 17, and Table 18).
Overall, the pass rates between the heterogeneous inserts and the uniform gel were comparable,
suggesting the validity of Monaco TPS calculations for heterogeneous environments when comparing
relatively to a scaled dose from T1-weighted MR signal intensities. Future work should include more
rigorous cross-validation of Monaco TPS with absolute dose calculations.

5.3 Homogeneous FXG phantom and ArcCHECK-MR results and discussion
After delivery of 3D plans onto rFOX inside an anthropomorphic head and neck phantom, stepand-shoot IMRT plans were investigated next based off of TG-119 IMRT Commissioning Tests [174,
175]. These plans were delivered onto two liter-sized uniform FXG phantoms. Some difficulties with
using rFOX in large sizes above one liter resulted in the use of the FXG formulation for this proof of
concept study of delivering TG-119 plans onto volumetric, MR-visible, and radiation-sensitive
dosimeters. Because rFOX was not stable in just gelatin, agarose was added as a gel matrix component.
The advantage of the addition of agarose for gel stability was due to its higher melting point and greater
rigidity; however, in the context of making gels larger than one liter, this higher melting point make it
more difficult to dissolve the rFOX components in a uniform manner and uniform distribution of the
formulation during cooling. For these reasons, as an initial proof of concept of using a Fricke-type gel
for more complex plan assessment, the FXG formulation was used instead. The FXG formulation has
been fully characterized for dose distribution calculations from both MR signal intensities and from
quantified T1 or R1 values in the literature [176–181]. Alongside the FXG phantoms, the plans were
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delivered onto quasi-3D ArcCHECK-MR for comparison. Sun Nuclear provided an MR-compatible
ArcCHECK-MR for MR-IGRT systems and had been previously investigated for such applications
[163, 164, 182]. Without the guidance of lasers and a light field and since the ArcCHECK cannot be
MR imaged, radio-opaque ceramic BB markers were positioned on its isocenter crosshairs to position
in the MR-Linac using the electronic portal imaging device (EPID) (Figure 66). Although the
ArcCHECK-MR does not provide a fully 3D dose distribution, it was included in this comparison with
FXG as a benchmark for acceptable gamma pass rates since the MR-Linac was still a pre-clinical
system. Most notably, rigorous MLC calibration and MR to MV isocenter registration had not yet been
completed at the time of this dissertation work, affecting the delivery of IMRT plans and the accuracy
of adapted plans based on daily MR images.
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Figure 66: a) and b) Images of ArcCHECK-MR showing locations of radio-opaque ceramic BB
markers, c) view of BB on EPID with gantry angle at 0º (BB should be in center of field of view if
positioned correctly, side BBs not visible in this acquisition due to size of EPID field of view), d) view
of BB on EPID with gantry angle at 90º or 270º (BBs should be centered and overlap if positioned
correctly), e) example of mis-aligned ArcCHECK-MR with BBs not overlapping, f) CT of BB used for
initial isocenter positioning in Monaco TPS, and g) CT of BBs on ArcCHECK-MR used for initial
isocenter positioning in Monaco TPS.

Similar to the heterogeneous rFOX phantom study, the FXG gel was MR imaged prior to
irradiation and post-irradiation using T2-weighted, T1-weighted T1 CE, and T1-weighted no CE
sequences with the same sequence parameters as for rFOX. Contrary to rFOX, the FXG had a greater
T2-weighted change and an insignificant T1-weighted no CE change (nearly all voxels failed using
gamma comparison with the Monaco TPS plan) (Figure 71). However, the post-irradiation T2-weighted
images were not used for dose distribution analysis since previous studies have shown the T2 response
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to be non-linear with respect to dose [82]. The overall 3D gamma pass rates are listed in Table 19.
Figures including the CT of large uniform FXG, T1-weighted T1 CE image, Monaco TPS dose overlaid
on CT, T1 CE relative dose, example gamma map of T1 CE dose, Monaco TPS dose on CT of
ArcCHECK-MR, and delivered and planned relative dose comparisons are presented below for the AP
PA plan (Figure 67), MultiTarget plan (Figure 68), Prostate plan (Figure 69), Head/Neck plan (Figure
70), and C-shape plan (Figure 71). The AP PA plan is a simple rectangular plan that could be delivered
in the shortest amount of time with only 2 parallel opposing beams (gantry angles 0° and 180°). The
MultiTarget plan consisted of 7 beams (gantry angles 0°, 50°, 100°, 150°, 210°, 260°, and 310°) and
dose constraints identified for three cylindrical targets (central, superior, and inferior). The Prostate
plan consisted of 7 beams (gantry angles 0°, 50°, 100°, 150°, 210°, 260°, and 310°) and dose constraints
identified for the prostate planning target volume (PTV), rectum, and bladder. The Head/Neck plan
consisted of 9 beams (gantry angles 0°, 40°, 80°, 120°, 160°, 200°, 240°, 280°, and 320°) and dose
constraints identified for the head/neck PTV, spinal cord, and parotids. The C-shape plan consisted of
9 beams (gantry angles 0°, 40°, 80°, 120°, 160°, 200°, 240°, 280°, and 320°) and dose constraints
identified for the C-shape PTV and core. The MultiTarget plan had a total of 36 segments; the Prostate
plan had a total of 28 segments; the Head/Neck plan had a total of 65 segments; and the C-shape plan
had a total of 55 segments. The plans were all delivered as step-and-shoot IMRT plans, so the greater
the number of segments, the overall time of treatment delivery was also longer.
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Table 19: 3D gamma pass rates for TG-119 plans. Pass rates above the 80% cutoff are highlighted in
green.
FXG
FXG
FXG
FXG
FXG
Arc-CHECK
FXG
FXG
FXG
FXG
FXG
Arc-CHECK
FXG
FXG
FXG
FXG
Arc-CHECK
FXG
Arc-CHECK
FXG
Arc-CHECK

MRI
T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
-------T1 CE
T1 CE
T1 CE
T1 CE
T1 CE
-------T1 CE
T1 CE
T1 CE
T1 CE
-------T1 CE
-------T1 CE
--------

NSA
1
2
3
4
5
-1
2
3
4
5
-1
2
3
4
-1
-1
--

TG-119 Plan
AP PA
AP PA
AP PA
AP PA
AP PA
AP PA
MultiTarget
MultiTarget
MultiTarget
MultiTarget
MultiTarget
MultiTarget
Prostate
Prostate
Prostate
Prostate
Prostate
Head/Neck
Head/Neck
C-Shape
C-Shape

7%/4mm
98.68%
98.98%
99.06%
99.02%
99.01%
-------96.07%
96.15%
95.99%
96.73%
96.38%
-------96.12%
95.57%
97.21%
97.94%
-------94.28%
-------94.79%
--------

5%/3mm
92.24%
92.65%
94.06%
94.34%
94.07%
-------48.50%
46.70%
50.07%
54.15%
56.35%
-------47.16%
42.86%
54.56%
61.04%
-------44.82%
-------47.94%
--------

3%/3mm
82.01%
81.23%
84.61%
85.92%
85.88%
100.0%
30.62%
29.19%
31.56%
34.87%
36.02%
91.6%
29.12%
26.36%
34.87%
39.78%
94.5%
27.56%
93.8%
29.99%
86.8%
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Figure 67: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for AP PA TG-119 plan.
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Figure 68: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for MultiTarget TG-119
plan.
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Figure 69: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for Prostate TG-119 plan.
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Figure 70: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for Head/Neck TG-119
plan.
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Figure 71: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) T1-weighted no CE image,
d) T2-weighted image, e) Monaco TPS dose overlaid on CT, f) T1 CE relative dose, g) no CE relative
dose, h) T2-weighted relative dose, i) gamma map of T1 CE dose, j) gamma map of no CE dose, k)
gamma map of T2-weighted dose, l) Monaco TPS dose on CT of ArcCHECK-MR, and m) delivered
and planned relative dose comparisons for C-Shape TG-119 plan.
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5.4 Summary
This work was the first to use heterogeneous MR-visible and radiation-sensitive 3D dosimeters
for full end-to-end testing in an MR-IGRT system. All heterogeneous rFOX dosimeters’ relative doses
passed for gamma criteria of 7%/4mm, more than half passed for 5%/3mm, and none passed for
3%/3mm. As mentioned previously, the heterogeneous rFOX dosimeter work was completed prior to
bug fixes in Monaco TPS so the adapted plans were not created and delivered exactly through the
planned workflow; as a result, lower gamma pass rates were expected. Since heterogeneous phantoms
were more susceptible to spatial dose accuracy, this work would be beneficial to be repeated once the
MR-Linac is no longer pre-clinical. However, the 7%/4mm gamma criteria pass rates (>90%) were
sufficient to demonstrate the proof of concept of using heterogeneous anthropomorphic rFOX
dosimeters for 3D dose distribution assessment with the MR-IGRT workflow.
The homogeneous large FXG dosimeters used for TG-119 IMRT plan evaluation passed for all
7%/4mm gamma criteria. However, compared to the rFOX 3D plan results, the FXG gamma pass rates
dropped more steeply for 5%/3mm and 3%/3mm for all IMRT plans except for the AP PA plan. This
rapid drop in gamma pass rates with tighter gamma criteria could be attributed to the longer plan
delivery times for the complex step-and-shoot IMRT plans compared to the AP PA plan and 3D plans
used with rFOX. During this time frame, some diffusion of signal may have occurred; a rigorous
assessment of dose rate dependence, fractionation, and other characteristics was also not completed in
this dissertation work for FXG. Since the gamma pass rates were above 94% with 7%/4mm gamma
criteria, it could be assumed that FXG responded linearly with dose for these plans. Future work should
either utilize fewer control points for the TG-119 plans or incorporate FXG or another formulation into
a gel matrix that has less diffusion compared to only gelatin.
The effect of NSA on gamma pass rates was also investigated for the homogeneous large FXG
dosimeters. NSA = 3 or 4 resulted in the greatest pass rates by up to 1.8% compared to NSA = 1 with
the MedianImageFilter with radius 1 applied. However, the MRI acquisition time rose linearly with
NSA (NSA = 3 required 3 x length of time required for NSA = 1). With only an increase in pass rate
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by up to 1.8% for NSA = 3 or 4, applying post-processing filters to images acquired with NSA = 1
would be recommended when diffusion was of concern.
This work was the first to use a homogeneous MR-visible 3D dosimeter for full end-to-end
testing in an MR-IGRT system. Previous work used non-MR-visible 3D dosimeters, indicating that the
clinical adaptive plan workflow could not be used [108]. However, previous work with non-MR-visible
3D dosimeters did result in higher gamma pass rates with tighter criteria (3%/3mm), those results were
acquired with optical CT scanning methods that could measure high resolution signal with less noise
when compared to MRI. The benefit of using an MR-visible 3D dosimeter in this proof of concept was
to eliminate registration errors between prescans of the dosimeter, delivery of plan based on the
prescans orientation, and postscans of the dosimeter. The entire clinical workflow including daily MR
imaging for adaptive planning and all scans of the dosimeters could be completed in one MR-IGRT
system using an MR-visible 3D dosimeter, eliminating the need for an outside read-out system such as
an optical CT scanner. However, one advantage of non-MR-visible plastic dosimeters included reduced
diffusion, resulting in higher gamma pass rates for tighter criteria [108].
At the time of this dissertation work, the MR and MV isocenters had not yet been registered,
the MLCs had not yet undergone a rigorous calibration, and the MR-Linac had not yet been fully
commissioned and calibrated. For these reasons, the pass rates were not as high as expected for a fully
clinical system. Updates to the Monaco TPS and workflow were also still underway at the time of this
dissertation work. Under these limitations, the feasibility of using both heterogeneous and
homogeneous MR-visible and radiation-sensitive 3D dosimeters were confirmed with encouraging 3D
pass rates with gamma criteria of 7%/4mm.
Limitations of using Fricke-type gels, including rFOX and FXG, for volumetric dose
calculations include noise in the MR images. Reducing MR image noise requires longer scan times (for
example by acquiring with larger NSA). However, for rFOX, the MR signal intensities were
continuously dropping post-irradiation, making it difficult to acquire dosimetrically valuable MR
images with significantly longer scan times (on the scale of hours for a volumetric scan) (Figure 35).
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For FXG, while the MR signal intensity is not dropping, diffusion of iron ions distort the dose
distribution on the scale of hours for Fricke-type gels (Figure 34, Table 9, and Table 10).
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Chapter 6 – Conclusion

6.1 Summary and conclusion
The purpose of this dissertation was to demonstrate the feasibility and benefit of volumetric,
MR-visible, and radiation-sensitive detectors for MR-IGRT applications.
In Chapter 2, I investigated candidate volumetric gel formulations, both already presented in
the literature and novel formulations explored for this dissertation, for dosimetric value on MR-IGRT
systems. The FOX formulation was found to be the most optimal, both optically and with MRI, for
MR-IGRT applications (up to 114% greater optical response, 10% greater real-time MR response, and
46% greater post-irradiation T1-weighted MR response when compared to conventional FXG). I also
demonstrated for the first time that iron(III) reduction formulations were more sensitive to UV exposure
compared to megavoltage irradiations, and that iron(II) oxidation formulations were more sensitive to
megavoltage irradiations than UV exposure [114, 183].
In Chapter 3, I presented the characterization of my novel formulations FOX and rFOX. Dose
linearity, radiological properties, reproducibility, time stability, energy dependence, reusability of a
formulation, dose rate dependence, fractionation dependence, gel matrix dependence, and diffusion
were quantified. In all scenarios, FOX and rFOX were found to respond linearly with respect to dose
in real-time during irradiation and immediately post-irradiation.
In Chapter 4, I investigated strong magnetic field and gradient field/radiofrequency effects on
the response of FOX as well as optimization of MR sequences for the purposes of real-time imaging
during irradiation and immediate post-irradiation imaging for volumetric dose quantification of rFOX.
Minimal magnetic field and gradient field/radiofrequency field effects were found for FOX. Volume
dependence and gantry angle dependence were also investigated with minimal effects. Gantry angle
dependence was a new concept specific to MR-IGRT systems, where the gantry may not necessarily
be in the same position each time for MR imaging. Other MR considerations that were true for any
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MRI read-out technique, such as MRI artifacts, were also discussed. I was the first to investigate strong
magnetic field effects on a radiochromic gel dosimeter and was the first to investigate any gradient
field/radiofrequency effects on 3D dosimeters. I was also the first to investigate several MR
considerations specific to and not specific to MR-IGRT systems, such as gantry angle dependence on
MR imaging and the occurrence and mitigations for MR artifacts, respectively.
In Chapter 5, I examined the performance of rFOX and FXG as end-to-end quality assurance
devices both in heterogeneous and homogeneous phantoms for 3D plans and step-and-shoot IMRT
commissioning plans. TG-119 IMRT plan irradiations were completed alongside the quasi-3D
ArcCHECK-MR QA system. This work demonstrated the proof of concept of using rFOX and FXG in
both heterogeneous and homogeneous phantoms for end-to-end assessment of the MR-IGRT workflow
and relative dose comparisons with the Monaco TPS plan doses. I was the first to investigate
heterogeneous 3D dosimeters for MR-IGRT applications and the first to use 3D dosimeters as a full
end-to-end quality assurance tool for MR-IGRT, including adapting plans using daily MR images of
the dosimeters. Previous work on IMRT plan verification in MR-IGRT systems utilized non-MRvisible radiochromic plastic dosimeters [108]. Again, limitations of using Fricke-type gels, including
rFOX and FXG, for volumetric dose calculations include noise in the MR images. Reducing MR image
noise requires longer scan times (for example by acquiring with larger NSA). However, for rFOX, the
MR signal intensities were continuously dropping post-irradiation, making it difficult to acquire
dosimetrically valuable MR images with significantly longer scan times (on the scale of hours for a
volumetric scan) (Figure 35). For FXG, while the MR signal intensity is not dropping, diffusion of iron
ions distort the dose distribution on the scale of hours for Fricke-type gels (Figure 34, Table 9, and
Table 10).

6.3 Future works
Future work suggested include further investigations into other matrixes for radiochromic gels
to allow for their use without a container, to reduce diffusion, or as a deformable gel. A polymer gel
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based deformable gel was made by encasing in a thin latex material and could easily be translated for
radiochromic gel work [184–186]. Although my work was the first to demonstrate the proof of concept
of real-time 3D dose acquisition during irradiation, this work should be continued in a deformable gel
in a motion phantom [111–114]. There are currently two MRI-compatible motion phantoms available:
CIRS dynamic phantom and Modus QUASAR respiratory motion phantom. Respiratory motion has
remained a challenge in radiation therapy for reducing organs at risk dose while maintaining or reducing
local recurrence [187–189]. Motion phantom studies are necessary for testing translational
methodologies using MR-IGRT prior to patient treatment. Also of continued interest in the 3D
dosimetry field is a lung equivalent 3D dosimeter as well as in combination with other materials to
make realistic heterogeneous phantoms [190–192]. I also encourage further characterization of FOX
and rFOX along with improved MR sequences for image quality in order to more accurately assess
IMRT plans with tighter gamma criteria. While long MR imaging sequences were avoided for rFOX
and FXG due to concerns with signal reversal and signal diffusion for rFOX and FXG, respectively,
further investigations into the most efficient MR imaging sequence to balance time with image quality
for volumetric dose distribution evaluation are recommended. This dissertation work investigated
relative 3D doses for rFOX and FXG; future work could include calibrating the dosimeter for absolute
3D doses. Suggestions have been made for internal calibrations of 3D dosimeters within a single
dosimeter for calibration and plan delivery [193].
Overall, this dissertation work encourages further investigations of MR-visible and radiationsensitive 3D dosimeters for MR-IGRT applications, both as a general quality assurance tool and as an
end-to-end test. I have done some initial work on investigating the use of 3D dosimeters for MRisocenter and MV-isocenter registration since other current methods lack a technique that is both MRvisible and radiation-sensitive [119]. During our initial experience with the MR-Linac workflow, it was
extremely beneficial to have an MR-visible and radiation-sensitive tool for following the workflow
end-to-end and to visually see where dose was being deposited (both optically and with MR images).
Especially since MR-IGRT workflows are not the same as conventional linac workflows, I especially
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encourage the use of 3D dosimeters for initial end-to-end experience before patient treatments are
delivered. My rFOX dosimeter can be imaged with CT and MRI, used for reference and adapted
planning practice, tracked with MRI in a motion phantom, can be incorporated into heterogeneous
anthropomorphic or homogeneous phantoms, irradiated with a plan, its relative 3D dose distribution
can be compared with the planned dose, and can be reused.
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